{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:33:14Z","timestamp":1792855994273,"version":"4.5.0"},"reference-count":781,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1124\/pharmrev.121.000348","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T19:00:13Z","timestamp":1670526013000},"page":"159-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":161,"title":["Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia\/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6424-6806","authenticated-orcid":false,"given":"P\u00e9ter","family":"Ferdinandy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1504-9942","authenticated-orcid":false,"given":"Ioanna","family":"Andreadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7887-6841","authenticated-orcid":false,"given":"Gary F.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6358-8962","authenticated-orcid":false,"given":"Hans Erik","family":"B\u00f8tker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5182-4980","authenticated-orcid":false,"given":"Sean M.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-117X","authenticated-orcid":false,"given":"Dobromir","family":"Dobrev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5605-900X","authenticated-orcid":false,"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7078-4160","authenticated-orcid":false,"given":"Gerd","family":"Heusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1942-8974","authenticated-orcid":false,"given":"Sandrine","family":"Lecour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4067-4638","authenticated-orcid":false,"given":"Marisol","family":"Ruiz-Meana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8361-2448","authenticated-orcid":false,"given":"Coert J.","family":"Zuurbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0729-4956","authenticated-orcid":false,"given":"Derek J.","family":"Hausenloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3017-0476","authenticated-orcid":false,"given":"Rainer","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pharmrev.121.000348_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00395-020-0816-0","article-title":"Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration","volume":"115","author":"Abbas","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib2","doi-asserted-by":"crossref","first-page":"105122","DOI":"10.1016\/j.bioorg.2021.105122","volume":"114","author":"Abdellatif","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1124\/pharmrev.121.000348_bib3","doi-asserted-by":"crossref","first-page":"10580","DOI":"10.1073\/pnas.1401591111","article-title":"An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore","volume":"111","author":"Alavian","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.121.000348_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/cvr\/cvv171","article-title":"Combination therapy with remote ischaemic conditioning and insulin or exenatide enhances infarct size limitation in pigs","volume":"107","author":"Alburquerque-B\u00e9jar","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1105819","article-title":"Apixaban with antiplatelet therapy after acute coronary syndrome","volume":"365","author":"Alexander","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib6","article-title":"Myocardial ischemia-reperfusion injury and the influence of inflammation","author":"Algoet","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"10.1124\/pharmrev.121.000348_bib7","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.cell.2014.10.045","article-title":"SnapShot: mammalian sirtuins","volume":"159","author":"Anderson","year":"2014","journal-title":"Cell"},{"key":"10.1124\/pharmrev.121.000348_bib8","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib9","doi-asserted-by":"crossref","first-page":"165770","DOI":"10.1016\/j.bbadis.2020.165770","article-title":"SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models","volume":"1866","author":"Andreadou","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1124\/pharmrev.121.000348_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2021.02.012","article-title":"Influence of cardiometabolic comorbidities on myocardial function, infarction, and cardioprotection: role of cardiac redox signaling","volume":"166","author":"Andreadou","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/pharmrev.121.000348_bib11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3389\/fphys.2017.01077","article-title":"Empagliflozin limits myocardial infarction in vivo and cell death in vitro: role of STAT3, mitochondria, and redox aspects","volume":"8","author":"Andreadou","year":"2017","journal-title":"Front Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cvr\/cvs121","article-title":"Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress","volume":"94","author":"Andreadou","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/bph.13704","article-title":"Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning","volume":"174","author":"Andreadou","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib14","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1111\/bph.14931","article-title":"Hyperlipidaemia and cardioprotection: animal models for translational studies","volume":"177","author":"Andreadou","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib15","doi-asserted-by":"crossref","first-page":"602497","DOI":"10.3389\/fphys.2020.602497","article-title":"PCSK9 in myocardial infarction and cardioprotection: importance of lipid metabolism and inflammation","volume":"11","author":"Andreadou","year":"2020","journal-title":"Front Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM199601043340102","article-title":"Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction","volume":"334","author":"Andreotti","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biochi.2019.01.011","article-title":"Hydrogen sulfide preconditioning could ameliorate reperfusion associated injury in diabetic cardiomyopathy rat heart through preservation of mitochondria","volume":"158","author":"Ansari","year":"2019","journal-title":"Biochimie"},{"key":"10.1124\/pharmrev.121.000348_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22457","article-title":"Diabetic animal fed with high-fat diet prevents the protective effect of myocardial ischemic preconditioning effect in isolated rat heart perfusion model","volume":"34","author":"Ansari","year":"2020","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1124\/pharmrev.121.000348_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12012-019-09542-9","article-title":"Mechanism of hydrogen sulfide preconditioning-associated protection against ischemia-reperfusion injury differs in diabetic heart that develops myopathy","volume":"20","author":"Ansari","year":"2020","journal-title":"Cardiovasc Toxicol"},{"key":"10.1124\/pharmrev.121.000348_bib20","doi-asserted-by":"crossref","first-page":"104322","DOI":"10.1016\/j.mvr.2022.104322","article-title":"Hydrogen sulfide postconditioning rendered cardioprotection against myocardial ischemia-reperfusion injury is compromised in rats with diabetic cardiomyopathy","volume":"141","author":"Ansari","year":"2022","journal-title":"Microvasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/path.4113","article-title":"Oxidative stress and myocardial injury in the diabetic heart","volume":"229","author":"Ansley","year":"2013","journal-title":"J Pathol"},{"key":"10.1124\/pharmrev.121.000348_bib22","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.jacc.2011.09.033","article-title":"Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation","volume":"58","author":"Arag\u00f3n","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.yjmcc.2004.12.001","article-title":"Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury","volume":"38","author":"Argaud","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCINTERVENTIONS.111.967596","article-title":"Treatment with OPN-305, a humanized anti-toll-like receptor-2 antibody, reduces myocardial ischemia\/reperfusion injury in pigs","volume":"5","author":"Arslan","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1124\/pharmrev.121.000348_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.109.880187","article-title":"Myocardial ischemia\/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody","volume":"121","author":"Arslan","year":"2010","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/eurheartj\/ehu331","article-title":"Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results","volume":"36","author":"Atar","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00395-018-0692-z","article-title":"Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function","volume":"113","author":"Audia","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3403959","article-title":"Effects of cardiac hypertrophy, diabetes, aging, and pregnancy on the cardioprotective effects of postconditioning in male and female rats","volume":"2019","author":"Babiker","year":"2019","journal-title":"Cardiol Res Pract"},{"key":"10.1124\/pharmrev.121.000348_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165777","article-title":"The interplay between the renin angiotensin system and pacing postconditioning induced cardiac protection","volume":"11","author":"Babiker","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib30","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/jpet.105.090803","article-title":"Gender differences in cardioprotection against ischemia\/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling","volume":"315","author":"Bae","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.121.000348_bib31","doi-asserted-by":"crossref","first-page":"100081","DOI":"10.1016\/j.ijchy.2021.100081","article-title":"The effect of remote ischaemic conditioning on blood pressure response: a systematic review and meta-analysis","volume":"8","author":"Baffour-Awuah","year":"2021","journal-title":"Int J Cardiol Hypertens"},{"key":"10.1124\/pharmrev.121.000348_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCRESAHA.118.314028","article-title":"Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury","volume":"124","author":"Bajpai","year":"2019","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00395-019-0770-x","article-title":"Tryptophane-kynurenine pathway in the remote ischemic conditioning mechanism","volume":"115","author":"Bakhta","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib34","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.CIR.90.2.1023","article-title":"Alpha-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning","volume":"90","author":"Bankwala","year":"1994","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12967-017-1166-z","article-title":"In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature","volume":"15","author":"Baranyai","year":"2017","journal-title":"J Transl Med"},{"key":"10.1124\/pharmrev.121.000348_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12933-015-0313-1","article-title":"Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning","volume":"14","author":"Baranyai","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1124\/pharmrev.121.000348_bib37","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.18632\/aging.101881","article-title":"Sex differences in the aging human heart: decreased sirtuins, pro-inflammatory shift and reduced anti-oxidative defense","volume":"11","author":"Barcena de Arellano","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1124\/pharmrev.121.000348_bib38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00395-014-0452-7","article-title":"Distinct cardioprotective mechanisms of immediate, early and delayed ischaemic postconditioning","volume":"110","author":"Barsukevich","year":"2015","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib39","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/bja\/aeh262","article-title":"Effect of lidocaine on ischaemic preconditioning in isolated rat heart","volume":"93","author":"Barthel","year":"2004","journal-title":"Br J Anaesth"},{"key":"10.1124\/pharmrev.121.000348_bib40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/cvr\/cvw216","article-title":"Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning","volume":"112","author":"Basalay","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.88.2.659","article-title":"Does preconditioning protect the coronary vasculature from subsequent ischemia\/reperfusion injury?","volume":"88","author":"Bauer","year":"1993","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00395-002-0366-7","article-title":"The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on","volume":"97","author":"Baxter","year":"2002","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s003950170041","article-title":"Delayed preconditioning of myocardium: current perspectives","volume":"96","author":"Baxter","year":"2001","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2017.11.003","article-title":"A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes","volume":"114","author":"Bayoumi","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1074248417729881","article-title":"Effect of ischemic postconditioning on myocardial function and infarct size following reperfusion injury in diabetic rats pretreated with vildagliptin","volume":"23","author":"Bayrami","year":"2018","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1124\/pharmrev.121.000348_bib46","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1053\/j.jvca.2016.07.005","article-title":"Cardioprotection by remote ischemic preconditioning is blocked in the aged rat heart in vivo","volume":"31","author":"Behmenburg","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1124\/pharmrev.121.000348_bib47","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1213\/ANE.0000000000002563","article-title":"Impact of anesthetic regimen on remote ischemic preconditioning in the rat heart in vivo","volume":"126","author":"Behmenburg","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1124\/pharmrev.121.000348_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00395-017-0628-z","article-title":"Exercise-induced circulating extracellular vesicles protect against cardiac ischemia-reperfusion injury","volume":"112","author":"Bei","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.14814\/phy2.12991","article-title":"Ischemia\/reperfusion-induced alterations of enzymatic and signaling functions of the rat cardiac Na+\/K+-ATPase: protection by ouabain preconditioning","volume":"4","author":"Belliard","year":"2016","journal-title":"Physiol Rep"},{"key":"10.1124\/pharmrev.121.000348_bib50","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3390\/cells9092134","article-title":"The rationale of neprilysin inhibition in prevention of myocardial ischemia-reperfusion injury during ST-elevation myocardial infarction","volume":"9","author":"Bellis","year":"2020","journal-title":"Cells"},{"key":"10.1124\/pharmrev.121.000348_bib51","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fphar.2018.00296","article-title":"Development of matrix metalloproteinase-2 inhibitors for cardioprotection","volume":"9","author":"Bencsik","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib52","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41569-021-00573-w","article-title":"A pathophysiological compass to personalize antianginal drug treatment","volume":"18","author":"Bertero","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib53","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.RES.65.3.695","article-title":"Intermittent coronary sinus occlusion after coronary arterial ligation results in venous retroperfusion","volume":"65","author":"Beyar","year":"1989","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/cvr\/cvy222","article-title":"Nitroglycerine limits infarct size through S-nitrosation of cyclophilin D: a novel mechanism for an old drug","volume":"115","author":"Bibli","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00395-016-0540-y","article-title":"Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies","volume":"111","author":"Bice","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib56","article-title":"Aspirin blocks the infarct-size limiting effect of ischemic postconditioning in the rat","author":"Birnbaum","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/pharmrev.121.000348_bib57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0008-6363(96)88632-9","article-title":"Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury","volume":"29","author":"Black","year":"1995","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8996482","article-title":"The roles of FGF21 and ALCAT1 in aerobic exercise-induced cardioprotection of postmyocardial infarction mice","volume":"2021","author":"Bo","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1124\/pharmrev.121.000348_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00395-019-0764-8","article-title":"Importance of infarct size versus other variables for clinical outcomes after PPCI in STEMI patients","volume":"115","author":"Bochaton","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.thromres.2018.05.015","article-title":"The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction","volume":"167","author":"Bode","year":"2018","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.121.000348_bib61","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2014.05.003","article-title":"Effect of ischemic postconditioning on microvascular obstruction in reperfused myocardial infarction. Results of a randomized study in patients and of an experimental model in swine","volume":"175","author":"Bodi","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCRESAHA.107.164699","article-title":"Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice","volume":"102","author":"Boengler","year":"2008","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib63","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cardiores.2005.04.014","article-title":"Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning","volume":"67","author":"Boengler","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib64","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00395-010-0124-1","article-title":"Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia\/reperfusion","volume":"105","author":"Boengler","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib65","doi-asserted-by":"crossref","first-page":"H1764","DOI":"10.1152\/ajpheart.01071.2006","article-title":"Loss of ischemic preconditioning\u2019s cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43","volume":"292","author":"Boengler","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib66","doi-asserted-by":"crossref","first-page":"H1215","DOI":"10.1152\/ajpheart.00124.2018","article-title":"Mitochondria \u201cTHE\u201d target of myocardial conditioning","volume":"315","author":"Boengler","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib67","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/cvr\/cvp033","article-title":"Loss of cardioprotection with ageing","volume":"83","author":"Boengler","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00395-009-0007-5","article-title":"Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria","volume":"104","author":"Boengler","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fphar.2013.00073","article-title":"Connexin 43 impacts on mitochondrial potassium uptake","volume":"4","author":"Boengler","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib70","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.2174\/138161281939131127115940","article-title":"The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formation","volume":"19","author":"Boengler","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pharmrev.121.000348_bib71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00395-021-00874-8","article-title":"CAESAR\u2019s legacy: a new era of rigor in preclinical studies of cardioprotection","volume":"116","author":"Bolli","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib72","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.15252\/embr.201643602","article-title":"Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation","volume":"18","author":"Bonora","year":"2017","journal-title":"EMBO Rep"},{"key":"10.1124\/pharmrev.121.000348_bib73","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/eurheartj\/ehi645","article-title":"Is atrial fibrillation an inflammatory disorder?","volume":"27","author":"Boos","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib74","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2018.11.123","article-title":"The imminent epidemic of atrial fibrillation and its concomitant diseases\u2014myocardial infarction and heart failure\u2014a cause for concern","volume":"287","author":"B\u00f6rschel","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib75","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/diabetes.54.1.146","article-title":"Glucagon-like peptide 1 can directly protect the heart against ischemia\/reperfusion injury","volume":"54","author":"Bose","year":"2005","journal-title":"Diabetes"},{"key":"10.1124\/pharmrev.121.000348_bib76","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/1074248420937871","article-title":"The future of cardioprotection-pointing toward patients at elevated risk as the target populations","volume":"25","author":"B\u00f8tker","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1124\/pharmrev.121.000348_bib77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00395-018-0696-8","article-title":"Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection","volume":"113","author":"B\u00f8tker","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib78","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(09)62001-8","article-title":"Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial","volume":"375","author":"B\u00f8tker","year":"2010","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.121.000348_bib79","doi-asserted-by":"crossref","first-page":"H1225","DOI":"10.1152\/ajpheart.00027.2018","article-title":"Clinical translation of myocardial conditioning","volume":"314","author":"B\u00f8tker","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib80","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13564","article-title":"Defective dimerization of FoF1-ATP synthase secondary to glycation favors mitochondrial energy deficiency in cardiomyocytes during aging","volume":"21","author":"Bou-Teen","year":"2022","journal-title":"Aging Cell"},{"key":"10.1124\/pharmrev.121.000348_bib81","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2021.02.043","article-title":"Mitochondrial ROS and mitochondria-targeted antioxidants in the aged heart","volume":"167","author":"Bou-Teen","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/pharmrev.121.000348_bib82","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11906-020-01092-8","article-title":"A contemporary approach to hypertensive cardiomyopathy: reversing left ventricular hypertrophy","volume":"22","author":"Bourdillon","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"10.1124\/pharmrev.121.000348_bib83","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/cells9030551","article-title":"Hidden cardiotoxicity of rofecoxib can be revealed in experimental models of ischemia\/reperfusion","volume":"9","author":"Brenner","year":"2020","journal-title":"Cells"},{"key":"10.1124\/pharmrev.121.000348_bib84","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/cvr\/26.5.518","article-title":"Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol","volume":"26","author":"Bril","year":"1992","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib85","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/01.CIR.91.2.393","article-title":"Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion","volume":"91","author":"Buerke","year":"1995","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib87","article-title":"Pathobiology of myocardial ischemia and reperfusion injury: models, modes, molecular mechanisms, modulation and clinical applications","author":"Buja","year":"2022","journal-title":"Cardiol Rev"},{"key":"10.1124\/pharmrev.121.000348_bib88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/clc.23110","article-title":"Platelet inhibition to target reperfusion injury trial: rationale and study design","volume":"42","author":"Bulluck","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib89","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.004940","article-title":"Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused ST-segment-elevation myocardial infarction and adverse left ventricular remodeling","volume":"9","author":"Bulluck","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1124\/pharmrev.121.000348_bib90","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.yjmcc.2009.02.026","article-title":"Cardioprotection by metabolic shut-down and gradual wake-up","volume":"46","author":"Burwell","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib91","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00109-020-01932-9","article-title":"Arginine derivatives in atrial fibrillation progression phenotypes","volume":"98","author":"B\u00fcttner","year":"2020","journal-title":"J Mol Med (Berl)"},{"key":"10.1124\/pharmrev.121.000348_bib92","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yjmcc.2019.03.007","article-title":"Circular RNA Ttc3 regulates cardiac function after myocardial infarction by sponging miR-15b","volume":"130","author":"Cai","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib93","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10522-016-9646-8","article-title":"Pre- and post-conditioning hormesis in elderly mice, rats, and humans: its loss and restoration","volume":"17","author":"Calabrese","year":"2016","journal-title":"Biogerontology"},{"key":"10.1124\/pharmrev.121.000348_bib94","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.phrs.2015.12.021","article-title":"Preconditioning is hormesis part I: documentation, dose-response features and mechanistic foundations","volume":"110","author":"Calabrese","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.121.000348_bib95","doi-asserted-by":"crossref","first-page":"563","DOI":"10.12688\/f1000research.10963.1","article-title":"Is there a role for ischaemic conditioning in cardiac surgery?","volume":"6","author":"Candilio","year":"2017","journal-title":"F1000 Res"},{"key":"10.1124\/pharmrev.121.000348_bib96","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/heartjnl-2014-306178","article-title":"Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial","volume":"101","author":"Candilio","year":"2015","journal-title":"Heart"},{"key":"10.1124\/pharmrev.121.000348_bib97","doi-asserted-by":"crossref","first-page":"101441","DOI":"10.1016\/j.redox.2020.101441","article-title":"An emerging perspective on sex differences: intersecting S-nitrosothiol and aldehyde signaling in the heart","volume":"31","author":"Casin","year":"2020","journal-title":"Redox Biol"},{"key":"10.1124\/pharmrev.121.000348_bib98","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/SHK.0000000000000500","article-title":"Remote ischemic conditioning influences mitochondrial dynamics","volume":"45","author":"Cellier","year":"2016","journal-title":"Shock"},{"key":"10.1124\/pharmrev.121.000348_bib99","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3389\/fphar.2019.00547","article-title":"Effects of non-statin lipid-modifying agents on cardiovascular morbidity and mortality among statin-treated patients: a systematic review and network meta-analysis","volume":"10","author":"Chaiyasothi","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib100","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003891","article-title":"Metabolic signature of remote ischemic preconditioning involving a cocktail of amino acids and biogenic amines","volume":"5","author":"Chao de la Barca","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pharmrev.121.000348_bib101","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1053\/j.jvca.2016.03.131","article-title":"Attenuation of isoflurane preconditioning-induced acute cardioprotection in hypertensive hypertrophied hearts","volume":"30","author":"Chen","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1124\/pharmrev.121.000348_bib102","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ijcard.2016.06.200","article-title":"Involvement of exogenous H2S in recovery of cardioprotection from ischemic post-conditioning via increase of autophagy in the aged hearts","volume":"220","author":"Chen","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib103","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jss.2016.03.052","article-title":"Hyperglycemia attenuates remifentanil postconditioning-induced cardioprotection against hypoxia\/reoxygenation injury in H9c2 cardiomyoblasts","volume":"203","author":"Chen","year":"2016","journal-title":"J Surg Res"},{"key":"10.1124\/pharmrev.121.000348_bib104","doi-asserted-by":"crossref","first-page":"H787","DOI":"10.1152\/ajpheart.00531.2017","article-title":"Intermediary metabolism and fatty acid oxidation: novel targets of electron transport chain-driven injury during ischemia and reperfusion","volume":"314","author":"Chen","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib105","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ahj.2015.07.014","article-title":"Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"170","author":"Chen","year":"2015","journal-title":"Am Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib106","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.cjca.2019.11.029","article-title":"Field implementation of remote ischemic conditioning in st-segment-elevation myocardial infarction: The FIRST Study","volume":"36","author":"Cheskes","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib107","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/ALN.0000000000000331","article-title":"Cyclosporine protects the heart during aortic valve surgery","volume":"121","author":"Chiari","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1124\/pharmrev.121.000348_bib108","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/ijms20020269","article-title":"Sevoflurane, propofol and carvedilol block myocardial protection by limb remote ischemic preconditioning","volume":"20","author":"Cho","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib109","first-page":"164","article-title":"Chronic remote ischemic conditioning for cardiovascular protection","volume":"2","author":"Chong","year":"2019","journal-title":"Cond Med"},{"key":"10.1124\/pharmrev.121.000348_bib110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nm.3212","article-title":"Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I","volume":"19","author":"Chouchani","year":"2013","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.121.000348_bib111","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature13909","article-title":"Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS","volume":"515","author":"Chouchani","year":"2014","journal-title":"Nature"},{"key":"10.1124\/pharmrev.121.000348_bib112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.carpath.2017.12.003","article-title":"Survival kinase-dependent pathways contribute to gender difference in the response to myocardial ischemia-reperfusion and ischemic post-conditioning","volume":"33","author":"Ciocci Pardo","year":"2018","journal-title":"Cardiovasc Pathol"},{"key":"10.1124\/pharmrev.121.000348_bib113","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/CIRCRESAHA.107.167072","article-title":"Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation","volume":"102","author":"Clarke","year":"2008","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib114","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00395-017-0653-y","article-title":"The impact of irreproducibility and competing protection from P2Y12 antagonists on the discovery of cardioprotective interventions","volume":"112","author":"Cohen","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00395-008-0737-9","article-title":"Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning\u2019s success","volume":"103","author":"Cohen","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib116","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.121.000348_bib117","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1067\/mhj.2002.123835","article-title":"Reduced microvascular and myocardial damage in patients with acute myocardial infarction and preinfarction angina","volume":"144","author":"Colonna","year":"2002","journal-title":"Am Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib118","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12933-020-0994-y","article-title":"Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction","volume":"19","author":"Connelly","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1124\/pharmrev.121.000348_bib119","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib120","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.3390\/ijms22084151","article-title":"Citric acid cycle metabolites predict infarct size in pigs submitted to transient coronary artery occlusion and treated with succinate dehydrogenase inhibitors or remote ischemic perconditioning","volume":"22","author":"Consegal","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib121","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1159\/000185547","article-title":"Post-conditioning preserves glycolytic ATP during early reperfusion: a survival mechanism for the reperfused heart","volume":"22","author":"Correa","year":"2008","journal-title":"Cell Physiol Biochem"},{"key":"10.1124\/pharmrev.121.000348_bib122","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jcin.2013.05.011","article-title":"Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial","volume":"6","author":"Crimi","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1124\/pharmrev.121.000348_bib123","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jss.2006.01.030","article-title":"Postconditioning in females depends on injury severity","volume":"134","author":"Crisostomo","year":"2006","journal-title":"J Surg Res"},{"key":"10.1124\/pharmrev.121.000348_bib124","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/10715762.2015.1006212","article-title":"Subsarcolemmal and interfibrillar mitochondria display distinct superoxide production profiles","volume":"49","author":"Crochemore","year":"2015","journal-title":"Free Radic Res"},{"key":"10.1124\/pharmrev.121.000348_bib125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pharmthera.2004.10.001","article-title":"Cardioprotective effects of glyceryl trinitrate: beyond vascular nitrate tolerance","volume":"105","author":"Csont","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pharmrev.121.000348_bib126","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","article-title":"Cyclosporine before PCI in patients with acute myocardial infarction","volume":"373","author":"Cung","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib127","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12265-019-9863-z","article-title":"Beyond reperfusion: acute ventricular unloading and cardioprotection during myocardial infarction","volume":"12","author":"Curran","year":"2019","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1124\/pharmrev.121.000348_bib128","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1139\/y2012-085","article-title":"High cholesterol diet effects on ischemia-reperfusion injury of the heart","volume":"90","author":"D\u2019Annunzio","year":"2012","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib129","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.exger.2009.02.005","article-title":"Ischemic preconditioning maintains cardioprotection in aging normotensive and spontaneously hypertensive rats","volume":"44","author":"Dai","year":"2009","journal-title":"Exp Gerontol"},{"key":"10.1124\/pharmrev.121.000348_bib130","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.2174\/1381612827666210125155821","article-title":"Vascular and cardiac oxidative stress and inflammation as targets for cardioprotection","volume":"27","author":"Daiber","year":"2021","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pharmrev.121.000348_bib131","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1440-1681.2012.05749.x","article-title":"Effects of fatty acids on cardioprotection by pre-ischaemic inhibition of the malate-aspartate shuttle","volume":"39","author":"Dalgas","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib132","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2021.01.036","article-title":"Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia\/reperfusion injury","volume":"165","author":"Dambrova","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/pharmrev.121.000348_bib133","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1111\/jcmm.15127","article-title":"Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury","volume":"24","author":"Davidson","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1124\/pharmrev.121.000348_bib134","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/cvr\/cvy314","article-title":"Circulating blood cells and extracellular vesicles in acute cardioprotection","volume":"115","author":"Davidson","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week","volume":"73","author":"Davidson","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib136","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.biocel.2005.09.017","article-title":"Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection","volume":"38","author":"Davidson","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1124\/pharmrev.121.000348_bib137","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/jcmm.13302","article-title":"Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non-diabetic exosomes in vitro","volume":"22","author":"Davidson","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1124\/pharmrev.121.000348_bib138","doi-asserted-by":"crossref","first-page":"15885","DOI":"10.1038\/s41598-018-34357-z","article-title":"Endothelial cells release cardioprotective exosomes that may contribute to ischaemic preconditioning","volume":"8","author":"Davidson","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000348_bib139","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.4244\/EIJ-D-18-00378","volume":"14","author":"De Maria","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1124\/pharmrev.121.000348_bib140","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib141","first-page":"H700","article-title":"Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury","volume":"265","author":"DeFily","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib142","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1024797530152","article-title":"Absence of ischemic preconditioning protection in diabetic sheep hearts: role of sarcolemmal KATP channel dysfunction","volume":"249","author":"del Valle","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/pharmrev.121.000348_bib143","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jcin.2015.09.010","article-title":"Thrombus aspiration in patients with ST-segment elevation myocardial infarction presenting late after symptom onset","volume":"9","author":"Desch","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1124\/pharmrev.121.000348_bib144","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1074\/jbc.M006825200","article-title":"Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart","volume":"276","author":"Di Lisa","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.121.000348_bib145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1291\/hypres.28.191","article-title":"Hypertensive heart disease","volume":"28","author":"Diamond","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1124\/pharmrev.121.000348_bib146","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/01.ASN.0000130154.42061.C6","article-title":"Increased infarct size in uremic rats: reduced ischemia tolerance?","volume":"15","author":"Dikow","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pharmrev.121.000348_bib147","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000313846","article-title":"Uremia aggravates left ventricular remodeling after myocardial infarction","volume":"32","author":"Dikow","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1124\/pharmrev.121.000348_bib148","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/cvr\/cvy128","article-title":"PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy","volume":"114","author":"Ding","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib149","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41569-019-0166-5","article-title":"Postoperative atrial fibrillation: mechanisms, manifestations and management","volume":"16","author":"Dobrev","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1113\/expphysiol.2012.066217","article-title":"Role of the parasympathetic nervous system in cardioprotection by remote hindlimb ischaemic preconditioning","volume":"98","author":"Donato","year":"2013","journal-title":"Exp Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib151","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.carpath.2011.07.008","article-title":"Histological correlate of a cardiac magnetic resonance imaged microvascular obstruction in a porcine model of ischemia-reperfusion","volume":"21","author":"Driesen","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"10.1124\/pharmrev.121.000348_bib152","first-page":"2451","article-title":"Lycopene restores the effect of ischemic postconditioning on myocardial ischemia-reperfusion injury in hypercholesterolemic rats","volume":"43","author":"Duan","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1124\/pharmrev.121.000348_bib153","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/FJC.0000000000000549","article-title":"Preconditioning and postconditioning by cardiac glycosides in the mouse heart","volume":"71","author":"Duan","year":"2018","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib154","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/annrheumdis-2018-213089","article-title":"Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis","volume":"77","author":"Dubreuil","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1124\/pharmrev.121.000348_bib155","first-page":"100794","article-title":"The relation between the atrial blood supply and the complexity of acute atrial fibrillation","volume":"34","author":"Dudink","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1124\/pharmrev.121.000348_bib156","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1172\/JCI22493","article-title":"Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver","volume":"115","author":"Duranski","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.121.000348_bib157","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/joic.12064","article-title":"No cardioprotective benefit of ischemic postconditioning in patients with ST-segment elevation myocardial infarction","volume":"26","author":"Dwyer","year":"2013","journal-title":"J Interv Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib158","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.phrs.2006.10.004","article-title":"Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy","volume":"55","author":"Ebrahim","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.121.000348_bib159","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.exger.2007.04.005","article-title":"Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension","volume":"42","author":"Ebrahim","year":"2007","journal-title":"Exp Gerontol"},{"key":"10.1124\/pharmrev.121.000348_bib160","first-page":"100526","article-title":"Effect of pressure-controlled intermittent coronary sinus occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study","volume":"28","author":"Egred","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1124\/pharmrev.121.000348_bib161","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/01.CIR.90.3.1368","article-title":"Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide","volume":"90","author":"Ehring","year":"1994","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib162","first-page":"H886","article-title":"Cholinergic and alpha-adrenergic coronary vasomotion [corrected] with increasing ischemia-reperfusion injury","volume":"268","author":"Ehring","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib163","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/09537104.2015.1083543","article-title":"Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction","volume":"27","author":"Eicher","year":"2016","journal-title":"Platelets"},{"key":"10.1124\/pharmrev.121.000348_bib164","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib165","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1093\/eurheartj\/ehv463","article-title":"Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial","volume":"36","author":"Eitel","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib166","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.012290","article-title":"Ischemia from nonculprit stenoses is not associated with reduced culprit infarct size in patients with ST-segment-elevation myocardial infarction","volume":"14","author":"Ekstr\u00f6m","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1124\/pharmrev.121.000348_bib167","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S2213-8587(15)00121-7","article-title":"Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial","volume":"3","author":"El Messaoudi","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1124\/pharmrev.121.000348_bib168","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamacardio.2017.0022","article-title":"Effect of Ischemic postconditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: a randomized clinical trial","volume":"2","author":"Engstr\u00f8m","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib169","first-page":"55","article-title":"Repeat remote ischaemic pre-conditioning for improved cardiovascular function in humans: a systematic review","volume":"11","author":"Epps","year":"2016","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1124\/pharmrev.121.000348_bib170","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jacc.2013.12.027","volume":"63","author":"Erlinge","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib171","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001316","article-title":"Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trial","volume":"7","author":"Fabris","year":"2020","journal-title":"Open Heart"},{"key":"10.1124\/pharmrev.121.000348_bib172","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.molmed.2017.08.001","article-title":"NAD+ in aging: molecular mechanisms and translational implications","volume":"23","author":"Fang","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1124\/pharmrev.121.000348_bib173","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11010-006-9296-2","article-title":"Comparative effects of ischemic pre and postconditioning on ischemia-reperfusion injury in spontaneously hypertensive rats (SHR)","volume":"296","author":"Fantinelli","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/pharmrev.121.000348_bib174","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2011.10.103","article-title":"Participation of mitochondrial permeability transition pore in the effects of ischemic preconditioning in hypertrophied hearts: role of NO and mitoKATP","volume":"166","author":"Fantinelli","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00395-019-0771-9","article-title":"Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart","volume":"115","author":"Fender","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib176","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1160\/TH17-03-0219","article-title":"Protease-activated receptor PAR-4: an inducible switch between thrombosis and vascular inflammation?","volume":"117","author":"Fender","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.121.000348_bib177","doi-asserted-by":"crossref","first-page":"104257","DOI":"10.1016\/j.phrs.2019.104257","article-title":"Straight to the heart: pleiotropic antiarrhythmic actions of oral anticoagulants","volume":"145","author":"Fender","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.121.000348_bib178","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehy365","article-title":"Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications","volume":"40","author":"Ferdinandy","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib179","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.121.000348_bib180","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/pr.107.06002","article-title":"Interaction of cardiovascular risk factors with myocardial ischemia\/reperfusion injury, preconditioning, and postconditioning","volume":"59","author":"Ferdinandy","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.121.000348_bib181","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0165-6147(98)01212-7","article-title":"Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon?","volume":"19","author":"Ferdinandy","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib182","article-title":"Hypercholesterolemia antagonized heart adaptation and functional remodeling of the mitochondria observed in acute diabetes mellitus subjected to ischemia\/reperfusion injury","volume":"69","author":"Ferko","year":"2018","journal-title":"J Physiol Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib183","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jacc.2015.06.023","article-title":"Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia\/reperfusion","volume":"66","author":"Fern\u00e1ndez-Jim\u00e9nez","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl F","key":"10.1124\/pharmrev.121.000348_bib184","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/16.suppl_F.38","article-title":"Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection","volume":"16","author":"Feuerstein","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib185","first-page":"6","article-title":"Deleterious hemodynamic effects of thrombotic\/embolic materials on the distal myocardial vasculature","volume":"42","author":"Folts","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib186","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990\u20132015","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"key":"10.1124\/pharmrev.121.000348_bib187","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/eurheartj\/ehr297","article-title":"Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention","volume":"33","author":"Freixa","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib188","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/aas.13296","article-title":"Remote ischaemic preconditioning increases serum extracellular vesicle concentrations with altered micro-RNA signature in CABG patients","volume":"63","author":"Frey","year":"2019","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1124\/pharmrev.121.000348_bib189","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCRESAHA.120.317219","article-title":"Different DOACs control inflammation in cardiac ischemia-reperfusion differently","volume":"128","author":"Gadi","year":"2021","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00395-017-0618-1","article-title":"Mitochondrial Cx43 hemichannels contribute to mitochondrial calcium entry and cell death in the heart","volume":"112","author":"Gadicherla","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib191","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/CIRCULATIONAHA.111.049072","article-title":"Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4","volume":"125","author":"Galaup","year":"2012","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib192","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3390\/ijms23042087","article-title":"Network-assisted systems biology analysis of the mitochondrial proteome in a pre-clinical model of ischemia, revascularization and post-conditioning","volume":"23","author":"Gallinat","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib193","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/CIRCULATIONAHA.119.042640","article-title":"Small extracellular microvesicles mediated pathological communications between dysfunctional adipocytes and cardiomyocytes as a novel mechanism exacerbating ischemia\/reperfusion injury in diabetic mice","volume":"141","author":"Gan","year":"2020","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib194","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.121.000348_bib195","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6806427","article-title":"Effect of Rho-kinase and autophagy on remote ischemic conditioning-induced cardioprotection in rat myocardial ischemia\/reperfusion injury model","volume":"2022","author":"Gao","year":"2022","journal-title":"Cardiovasc Ther"},{"key":"10.1124\/pharmrev.121.000348_bib196","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.yjmcc.2012.01.010","article-title":"Myocardial edema: a translational view","volume":"52","author":"Garcia-Dorado","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib197","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00395-014-0422-0","article-title":"\u03b23 adrenergic receptor selective stimulation during ischemia\/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes","volume":"109","author":"Garc\u00eda-Prieto","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib198","doi-asserted-by":"crossref","first-page":"14780","DOI":"10.1038\/ncomms14780","article-title":"Neutrophil stunning by metoprolol reduces infarct size","volume":"8","author":"Garc\u00eda-Prieto","year":"2017","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.121.000348_bib199","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.jacc.2016.02.050","article-title":"Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function","volume":"67","author":"Garc\u00eda-Ruiz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00395-021-00842-2","article-title":"Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the myocardial infarct size: a two-by-two factorial randomized trial (COMBAT-MI)","volume":"116","author":"Garc\u00eda Del Blanco","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib201","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00395-018-0672-3","article-title":"Randomized controlled trial of remote ischaemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI)","volume":"113","author":"Gaspar","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib202","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/cvr\/cvab158","article-title":"The role of autophagy in cardiovascular pathology","volume":"118","author":"Gatica","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0008-6363(98)00319-8","article-title":"Ischaemic preconditioning changes the pattern of coronary reactive hyperaemia in the goat: role of adenosine and nitric oxide","volume":"42","author":"Gattullo","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib204","doi-asserted-by":"crossref","first-page":"E112","DOI":"10.1002\/ccd.27860","article-title":"The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry","volume":"93","author":"Ge","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1124\/pharmrev.121.000348_bib205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/ALN.0000000000001926","article-title":"Failure of isoflurane cardiac preconditioning in obese type 2 diabetic mice involves aberrant regulation of microRNA-21, endothelial nitric-oxide synthase, and mitochondrial complex I","volume":"128","author":"Ge","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1124\/pharmrev.121.000348_bib206","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s395-002-8386-0","article-title":"Xanthine oxidase contributes to preconditioning\u2019s preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning","volume":"97","author":"Gelpi","year":"2002","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib207","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1111\/1755-5922.12010","article-title":"The effect of prethrombolytic cyclosporine-A injection on clinical outcome of acute anterior ST-elevation myocardial infarction","volume":"31","author":"Ghaffari","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"10.1124\/pharmrev.121.000348_bib208","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.lfs.2018.10.035","article-title":"Mitochondrial dynamics as an underlying mechanism involved in aerobic exercise training-induced cardioprotection against ischemia-reperfusion injury","volume":"213","author":"Ghahremani","year":"2018","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.121.000348_bib209","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11886-021-01494-3","article-title":"Should we be using upstream beta-blocker therapy for acute myocardial infarction?","volume":"23","author":"Giannakopoulos","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1124\/pharmrev.121.000348_bib210","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/eurheartj\/ehv597","article-title":"EMBRACE STEMI study: a phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention","volume":"37","author":"Gibson","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib211","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1073\/pnas.1217823110","article-title":"Dimers of mitochondrial ATP synthase form the permeability transition pore","volume":"110","author":"Giorgio","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.121.000348_bib212","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12944-017-0455-0","article-title":"Hypercholesterolemia downregulates autophagy in the rat heart","volume":"16","author":"Giricz","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1124\/pharmrev.121.000348_bib213","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1124\/jpet.105.091140","article-title":"Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition","volume":"316","author":"Giricz","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.121.000348_bib214","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yjmcc.2014.01.004","article-title":"Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles","volume":"68","author":"Giricz","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib215","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.3390\/ijms22073467","article-title":"Adenosine A2A receptors are upregulated in peripheral blood mononuclear cells from atrial fibrillation patients","volume":"22","author":"Godoy-Mar\u00edn","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib216","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/eurheartj\/ehp046","article-title":"Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles","volume":"30","author":"Goette","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib217","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.hrthm.2016.05.028","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"14","author":"Goette","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1124\/pharmrev.121.000348_bib218","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.3390\/ijms21196990","article-title":"Cardioprotective effect of novel matrix metalloproteinase inhibitors","volume":"21","author":"G\u00f6m\u00f6ri","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib219","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.yexmp.2016.01.009","article-title":"Cyclosporine-A mimicked the ischemic pre- and postconditioning-mediated cardioprotection in hypertensive rats: role of PKC\u03b5","volume":"100","author":"Gonz\u00e1lez Arbel\u00e1ez","year":"2016","journal-title":"Exp Mol Pathol"},{"key":"10.1124\/pharmrev.121.000348_bib220","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/bs.pmbts.2015.07.002","article-title":"Exercise and regulation of adipokine and myokine production","volume":"135","author":"G\u00f6rgens","year":"2015","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1124\/pharmrev.121.000348_bib221","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/cvr\/cvaa061","article-title":"Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction: a substudy of the CONDI-2\/ERIC-PPCI randomized controlled trial","volume":"117","author":"Gorog","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib222","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ijcard.2016.06.212","article-title":"Rivaroxaban, a factor Xa inhibitor, induces the secondary prevention of cardiovascular events after myocardial ischemia reperfusion injury in mice","volume":"220","author":"Goto","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib223","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1399-6576.2011.02577.x","article-title":"Neutrophil inhibition contributes to cardioprotection by postconditioning","volume":"56","author":"Granfeldt","year":"2012","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1124\/pharmrev.121.000348_bib224","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib225","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s001250051236","article-title":"Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide","volume":"42","author":"Gribble","year":"1999","journal-title":"Diabetologia"},{"key":"10.1124\/pharmrev.121.000348_bib226","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211238","article-title":"Sevoflurane postconditioning is not mediated by ferritin accumulation and cannot be rescued by simvastatin in isolated streptozotocin-induced diabetic rat hearts","volume":"14","author":"Grievink","year":"2019","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib227","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006427","article-title":"Effect of blood flow restricted resistance exercise and remote ischemic conditioning on functional capacity and myocellular adaptations in patients with heart failure","volume":"12","author":"Groennebaek","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1124\/pharmrev.121.000348_bib228","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0735-1097(87)80310-8","article-title":"Intermittent coronary sinus occlusion in dogs: reduction of infarct size 10 days after reperfusion","volume":"9","author":"Guerci","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib229","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3390\/jcm9051366","article-title":"Adenosine and the cardiovascular system: the good and the bad","volume":"9","author":"Guieu","year":"2020","journal-title":"J Clin Med"},{"key":"10.1124\/pharmrev.121.000348_bib230","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/SHK.0000000000001412","article-title":"Direct rivaroxaban-induced factor XA inhibition proves to be cardioprotective in rats","volume":"53","author":"Guillou","year":"2020","journal-title":"Shock"},{"key":"10.1124\/pharmrev.121.000348_bib231","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/SHK.0000000000000970","article-title":"Chronic kidney disease exacerbates myocardial ischemia reperfusion injury: role of endoplasmic reticulum stress-mediated apoptosis","volume":"49","author":"Guo","year":"2018","journal-title":"Shock"},{"key":"10.1124\/pharmrev.121.000348_bib232","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12872-015-0071-8","article-title":"Preconditioning offers cardioprotection in hyperlipidemic rat hearts: possible role of dopamine (D2) signaling","volume":"15","author":"Gupta","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1124\/pharmrev.121.000348_bib233","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1152\/japplphysiol.90537.2008","article-title":"Ischemic preconditioning affects hexokinase activity and HKII in different subcellular compartments throughout cardiac ischemia-reperfusion","volume":"106","author":"Gurel","year":"2009","journal-title":"J Appl Physiol (1985)"},{"key":"10.1124\/pharmrev.121.000348_bib234","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1007\/s11033-013-2495-5","article-title":"Hexokinase cellular trafficking in ischemia-reperfusion and ischemic preconditioning is altered in type I diabetic heart","volume":"40","author":"Gurel","year":"2013","journal-title":"Mol Biol Rep"},{"key":"10.1124\/pharmrev.121.000348_bib235","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0735-1097(87)80212-7","article-title":"Regional myocardial blood flow, function and metabolism using phosphorus-31 nuclear magnetic resonance spectroscopy during ischemia and reperfusion in dogs","volume":"10","author":"Guth","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib236","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12933-016-0489-z","article-title":"Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes","volume":"16","author":"Habibi","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1124\/pharmrev.121.000348_bib237","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00395-018-0670-5","article-title":"The SAFE pathway for cardioprotection: is this a promising target?","volume":"113","author":"Hadebe","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib238","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.RES.68.1.61","article-title":"Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat","volume":"68","author":"Hagar","year":"1991","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib239","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.004234","article-title":"Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size","volume":"2","author":"Hale","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pharmrev.121.000348_bib240","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11239-014-1098-x","article-title":"Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia\/reperfusion","volume":"39","author":"Hale","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"10.1124\/pharmrev.121.000348_bib241","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yjmcc.2014.08.018","article-title":"The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia\/reperfusion injury","volume":"78","author":"Halestrap","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib242","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijcard.2016.07.229","article-title":"Effect of remote ischemic preconditioning on myocardial injury and inflammatory response induced by ablation for atrial fibrillation: a randomized controlled trial","volume":"222","author":"Han","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib243","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/pace.13271","article-title":"Effect of remote ischemic preconditioning on left atrial remodeling and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation","volume":"41","author":"Han","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1124\/pharmrev.121.000348_bib244","article-title":"Autophagy is involved in the cardioprotection effect of remote limb ischemic postconditioning on myocardial ischemia\/reperfusion injury in normal mice, but not diabetic mice","volume":"9","author":"Han","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib245","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1469-7793.1998.231bx.x","article-title":"Mechanisms of force inhibition by halothane and isoflurane in intact rat cardiac muscle","volume":"506","author":"Hanley","year":"1998","journal-title":"J Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib246","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2015.04.009","article-title":"Differences in the profile of protection afforded by TRO40303 and mild hypothermia in models of cardiac ischemia\/reperfusion injury","volume":"760","author":"Hansson","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib247","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.atherosclerosis.2015.03.023","article-title":"Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice","volume":"242","author":"Hara","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1124\/pharmrev.121.000348_bib248","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1536\/ihj.15-112","article-title":"Rivaroxaban inhibits angiotensin ii-induced activation in cultured mouse cardiac fibroblasts through the modulation of NF-\u03baB pathway","volume":"56","author":"Hashikata","year":"2015","journal-title":"Int Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib249","doi-asserted-by":"crossref","first-page":"H150","DOI":"10.1152\/ajpheart.00114.2018","article-title":"Influence of long-term treatment with glyceryl trinitrate on remote ischemic conditioning","volume":"315","author":"Hauerslev","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib250","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/heartjnl-2013-304845","article-title":"The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial","volume":"100","author":"Hausenloy","year":"2014","journal-title":"Heart"},{"key":"10.1124\/pharmrev.121.000348_bib251","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00395-016-0588-8","article-title":"Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery","volume":"111","author":"Hausenloy","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib252","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/cvr\/cvz053","article-title":"Cardiac innervation in acute myocardial ischaemia\/reperfusion injury and cardioprotection","volume":"115","author":"Hausenloy","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib253","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1413534","article-title":"Remote ischemic preconditioning and outcomes of cardiac surgery","volume":"373","author":"Hausenloy","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib254","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/cvr\/cvy286","article-title":"The coronary circulation in acute myocardial ischaemia\/reperfusion injury: a target for cardioprotection","volume":"115","author":"Hausenloy","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib255","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cvr\/cvx049","article-title":"Novel targets and future strategies for acute cardioprotection: position paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart","volume":"113","author":"Hausenloy","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib256","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(19)32039-2","article-title":"Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2\/ERIC-PPCI): a single-blind randomised controlled trial","volume":"394","author":"Hausenloy","year":"2019","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.121.000348_bib257","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0008-6363(02)00455-8","article-title":"Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?","volume":"55","author":"Hausenloy","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib258","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(07)61296-3","article-title":"Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial","volume":"370","author":"Hausenloy","year":"2007","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.121.000348_bib259","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00395-020-0794-2","article-title":"A future for remote ischaemic conditioning in high-risk patients","volume":"115","author":"Hausenloy","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib260","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1475-2840-12-154","article-title":"Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner","volume":"12","author":"Hausenloy","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1124\/pharmrev.121.000348_bib261","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cardiores.2003.09.024","article-title":"New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway","volume":"61","author":"Hausenloy","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib262","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/CIRCULATIONAHA.117.029859","article-title":"Combination therapy to target reperfusion injury after ST-segment-elevation myocardial infarction: a more effective approach to cardioprotection","volume":"136","author":"Hausenloy","year":"2017","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib263","doi-asserted-by":"crossref","first-page":"H841","DOI":"10.1152\/ajpheart.00678.2003","article-title":"Preconditioning protects by inhibiting the mitochondrial permeability transition","volume":"287","author":"Hausenloy","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib264","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/s41598-017-03653-5","article-title":"Atrial fibrillation as a prognostic indicator of myocardial infarction and cardiovascular death: a systematic review and meta-analysis","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000348_bib265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00395-020-00830-y","article-title":"The importance of clinically relevant background therapy in cardioprotective studies","volume":"115","author":"He","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib266","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/bph.13042","article-title":"Opioid receptors and cardioprotection\u2014\"opioidergic conditioning\u201d of the heart","volume":"172","author":"Headrick","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib267","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00018-021-04125-w","article-title":"Circulating cardiomyocyte-derived extracellular vesicles reflect cardiac injury during systemic inflammatory response syndrome in mice","volume":"79","author":"Hegyesi","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pharmrev.121.000348_bib268","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/CIRCRESAHA.120.316710","article-title":"Atrial myocyte NLRP3\/CaMKII nexus forms a substrate for postoperative atrial fibrillation","volume":"127","author":"Heijman","year":"2020","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib269","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12967-018-1480-0","article-title":"The release of cardioprotective humoral factors after remote ischemic preconditioning in humans is age- and sex-dependent","volume":"16","author":"Heinen","year":"2018","journal-title":"J Transl Med"},{"key":"10.1124\/pharmrev.121.000348_bib270","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.RES.0000181171.65293.65","article-title":"Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice","volume":"97","author":"Heinzel","year":"2005","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib271","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1111\/jcmm.15384","article-title":"Targeting mitochondrial fusion and fission proteins for cardioprotection","volume":"24","author":"Hernandez-Resendiz","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1124\/pharmrev.121.000348_bib272","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cardfail.2013.01.003","article-title":"Postconditioning protects against reperfusion injury in hypertensive dilated cardiomyopathy by activating MEK\/ERK1\/2 signaling","volume":"19","author":"Hern\u00e1ndez-Res\u00e9ndiz","year":"2013","journal-title":"J Card Fail"},{"key":"10.1124\/pharmrev.121.000348_bib273","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1093\/eurheartj\/ehu286","article-title":"Association between clinical presentations before myocardial infarction and coronary mortality: a prospective population-based study using linked electronic records","volume":"35","author":"Herrett","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib274","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.0000037520.89770.5E","article-title":"Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction","volume":"106","author":"Herrmann","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib275","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1161\/01.CIR.103.24.2876","article-title":"Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug?","volume":"103","author":"Heusch","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib276","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/eurheartj\/ehr341","article-title":"Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction?","volume":"33","author":"Heusch","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib277","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","article-title":"Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning","volume":"116","author":"Heusch","year":"2015","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib278","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCRESAHA.116.308640","article-title":"The coronary circulation as a target of cardioprotection","volume":"118","author":"Heusch","year":"2016","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib279","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","article-title":"Critical issues for the translation of cardioprotection","volume":"120","author":"Heusch","year":"2017","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib280","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1093\/eurheartj\/ehy253","article-title":"Cardioprotection research must leave its comfort zone","volume":"39","author":"Heusch","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib281","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00395-019-0756-8","article-title":"Coronary microvascular obstruction: the new frontier in cardioprotection","volume":"114","author":"Heusch","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib282","doi-asserted-by":"crossref","first-page":"H1439","DOI":"10.1152\/ajpheart.00139.2019","article-title":"Myocardial ischemia: lack of coronary blood flow, myocardial oxygen supply-demand imbalance, or what?","volume":"316","author":"Heusch","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib283","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCRESAHA.118.314331","article-title":"The spleen in myocardial infarction","volume":"124","author":"Heusch","year":"2019","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib284","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib285","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2014.10.031","article-title":"Remote ischemic conditioning","volume":"65","author":"Heusch","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib286","first-page":"774","article-title":"The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge","volume":"38","author":"Heusch","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib287","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCULATIONAHA.119.044176","article-title":"Is cardioprotection salvageable?","volume":"141","author":"Heusch","year":"2020","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib288","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1093\/eurheartj\/ehaa764","article-title":"Is metoprolol more cardioprotective than other beta-blockers?","volume":"41","author":"Heusch","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib289","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","article-title":"Cardiovascular remodelling in coronary artery disease and heart failure","volume":"383","author":"Heusch","year":"2014","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.121.000348_bib290","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.111.255604","article-title":"Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia\/reperfusion","volume":"109","author":"Heusch","year":"2011","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib291","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/CIRCRESAHA.111.259556","article-title":"STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication","volume":"110","author":"Heusch","year":"2012","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib292","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCRESAHA.116.308736","article-title":"Time to give up on cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning","volume":"119","author":"Heusch","year":"2016","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib293","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/01.CIR.65.1.62","article-title":"Determinants of myocardial hemorrhage after coronary reperfusion in the anesthetized dog","volume":"65","author":"Higginson","year":"1982","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib294","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00395-021-00861-z","article-title":"Connexin 43 phosphorylation by casein kinase 1 is essential for the cardioprotection by ischemic preconditioning","volume":"116","author":"Hirschh\u00e4user","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192981","article-title":"Influence of diabetes mellitus duration on the efficacy of ischemic preconditioning in a Zucker diabetic fatty rat model","volume":"13","author":"Hjortbak","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib296","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00395-021-00870-y","article-title":"Translation of experimental cardioprotective capability of P2Y12 inhibitors into clinical outcome in patients with ST-elevation myocardial infarction","volume":"116","author":"Hjortbak","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib297","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/2048872619830609","article-title":"Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a patient-pooled meta-analysis of randomized clinical trials","volume":"9","author":"Hoedemaker","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1124\/pharmrev.121.000348_bib298","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044667","article-title":"Cardiac subsarcolemmal and interfibrillar mitochondria display distinct responsiveness to protection by diazoxide","volume":"7","author":"Holmuhamedov","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib299","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00395-019-0724-3","article-title":"Acute and chronic remote ischemic conditioning attenuate septic cardiomyopathy, improve cardiac output, protect systemic organs, and improve mortality in a lipopolysaccharide-induced sepsis model","volume":"114","author":"Honda","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib300","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/eht346","article-title":"Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote ischaemic preconditioning with postconditioning outcome trial","volume":"35","author":"Hong","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib301","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/SHK.0000000000001296","article-title":"Pharmacological inhibition of PTEN restores remote ischemic postconditioning cardioprotection in hypercholesterolemic mice: potential role of PTEN\/AKT\/GSK3\u03b2 signals","volume":"52","author":"Hong","year":"2019","journal-title":"Shock"},{"key":"10.1124\/pharmrev.121.000348_bib302","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/cvr\/cvx165","article-title":"A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration","volume":"113","author":"Huang","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib303","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijcard.2009.09.551","article-title":"The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion","volume":"147","author":"Ibanez","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib304","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib305","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib306","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/CIRCULATIONAHA.106.679639","article-title":"Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance","volume":"115","author":"Ibanez","year":"2007","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib307","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0735-1097(01)01240-2","article-title":"Pre-infarction angina elicits greater myocardial viability on reperfusion after myocardial infarction: a dobutamine stress echocardiographic study","volume":"37","author":"Iglesias-Garriz","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib308","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00395-021-00851-1","article-title":"Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning study","volume":"116","author":"Ikonomidis","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib309","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00395-009-0078-3","article-title":"Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative\/nitrosative stress attenuation","volume":"105","author":"Iliodromitis","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib310","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.atherosclerosis.2005.11.023","article-title":"The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits","volume":"188","author":"Iliodromitis","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1124\/pharmrev.121.000348_bib311","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/cvr\/cvu163","article-title":"Delayed phospholamban phosphorylation in post-conditioned heart favours Ca2+ normalization and contributes to protection","volume":"103","author":"Inserte","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib312","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.005975","article-title":"Activation of cGMP\/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling","volume":"2","author":"Inserte","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pharmrev.121.000348_bib313","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/ars.2010.3312","article-title":"Contribution of delayed intracellular pH recovery to ischemic postconditioning protection","volume":"14","author":"Inserte","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/pharmrev.121.000348_bib314","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Swerdlow","year":"2012","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.121.000348_bib315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM198401053100103","article-title":"Reduction of infarct size with the early use of timolol in acute myocardial infarction","volume":"310","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib316","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/ehf2.12718","article-title":"Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus","volume":"7","author":"Iqbal","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1124\/pharmrev.121.000348_bib317","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0002-8703(00)90021-8","article-title":"Beneficial effect of prodromal angina pectoris is lost in elderly patients with acute myocardial infarction","volume":"139","author":"Ishihara","year":"2000","journal-title":"Am Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib318","doi-asserted-by":"crossref","first-page":"839436","DOI":"10.3389\/fendo.2022.839436","article-title":"Developmental origins of metaflammation; a bridge to the future between the DOHaD theory and evolutionary biology","volume":"13","author":"Itoh","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1124\/pharmrev.121.000348_bib319","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.yjmcc.2012.10.001","article-title":"Cytoprotective regulation of the mitochondrial permeability transition pore is impaired in type 2 diabetic Goto-Kakizaki rat hearts","volume":"53","author":"Itoh","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib320","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0735-1097(98)00441-0","article-title":"Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs","volume":"32","author":"Jalowy","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib321","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/eurheartj\/ehy232","article-title":"Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial","volume":"39","author":"Janssens","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib322","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/hrt.77.4.314","article-title":"Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery","volume":"77","author":"Jenkins","year":"1997","journal-title":"Heart"},{"key":"10.1124\/pharmrev.121.000348_bib323","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00395-012-0285-1","article-title":"Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients","volume":"107","author":"Jensen","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib324","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cvr\/cvs337","article-title":"Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients","volume":"97","author":"Jensen","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069910","article-title":"AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury","volume":"8","author":"Ji","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib326","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCRESAHA.116.305082","article-title":"Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction","volume":"116","author":"Jones","year":"2015","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib327","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/ehjcvp\/pvaa096","article-title":"The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction","volume":"7","author":"Jones","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1124\/pharmrev.121.000348_bib328","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/ajh\/hpu004","article-title":"Seven-day remote ischemic preconditioning improves local and systemic endothelial function and microcirculation in healthy humans","volume":"27","author":"Jones","year":"2014","journal-title":"Am J Hypertens"},{"key":"10.1124\/pharmrev.121.000348_bib329","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCRESAHA.116.305462","article-title":"The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs","volume":"116","author":"Jones","year":"2015","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib330","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2014.09.148","article-title":"Nlrp3 plays no role in acute cardiac infarction due to low cardiac expression","volume":"177","author":"Jong","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib331","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","article-title":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association","volume":"145","author":"Joseph","year":"2022","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib332","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00395-020-0783-5","article-title":"Mitochondrial noncoding RNA-regulatory network in cardiovascular disease","volume":"115","author":"Jusic","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib333","first-page":"H842","article-title":"Preconditioning prevents chronic reperfusion-induced coronary endothelial dysfunction in rats","volume":"271","author":"Kaeffer","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib334","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1161\/01.CIR.96.7.2311","article-title":"Delayed coronary endothelial protection 24 hours after preconditioning: role of free radicals","volume":"96","author":"Kaeffer","year":"1997","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib335","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijcard.2016.12.005","article-title":"No protection of heart, kidneys and brain by remote ischemic preconditioning before transfemoral transcatheter aortic valve implantation: Interim-analysis of a randomized single-blinded, placebo-controlled, single-center trial","volume":"231","author":"Kahlert","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib336","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/ejcts\/ezab500","article-title":"Effects of ischaemic postconditioning in aortic valve replacement: a multicenter randomized controlled trial","volume":"61","author":"Kaljusto","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1124\/pharmrev.121.000348_bib337","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/hrt.2006.108688","article-title":"The role of the post-cardioversion time course of HS-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation","volume":"94","author":"Kallergis","year":"2008","journal-title":"Heart"},{"key":"10.1124\/pharmrev.121.000348_bib338","article-title":"Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis","volume":"10","author":"Kanie","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pharmrev.121.000348_bib339","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00210-015-1105-6","article-title":"Effect of zinc supplements in the attenuated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart","volume":"388","author":"Kansal","year":"2015","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib340","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.118.038269","article-title":"Unloading the left ventricle before reperfusion in patients with anterior ST-segment-elevation myocardial infarction","volume":"139","author":"Kapur","year":"2019","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib341","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1053\/euhj.1999.1714","article-title":"Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina","volume":"20","author":"Karila-Cohen","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib342","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/1074248410362074","article-title":"Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model","volume":"15","author":"Karlsson","year":"2010","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1124\/pharmrev.121.000348_bib343","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of ischemic heart disease","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib344","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/CIRCRESAHA.114.305663","article-title":"Association of MicroRNAs and YRNAs with platelet function","volume":"118","author":"Kaudewitz","year":"2016","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib345","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib346","first-page":"468","article-title":"The combined effect of rosuvastatin and ischemic pre- or post-conditioning on myocardial ischemia-reperfusion injury in rat heart","volume":"219","author":"Kelle","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib347","doi-asserted-by":"crossref","first-page":"H1744","DOI":"10.1152\/ajpheart.2001.280.4.H1744","article-title":"Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels","volume":"280","author":"Kersten","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib348","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003393","article-title":"Sphingosine-1-phosphate receptor 1 regulates cardiac function by modulating Ca2+ sensitivity and Na+\/H+ exchange and mediates protection by ischemic preconditioning","volume":"5","author":"Keul","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pharmrev.121.000348_bib349","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.amjcard.2017.10.035","article-title":"Meta-analysis of the safety and efficacy of the oral anticoagulant agents (apixaban, rivaroxaban, dabigatran) in patients with acute coronary syndrome","volume":"121","author":"Khan","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib350","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.CIR.103.12.1624","article-title":"Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo","volume":"103","author":"Kharbanda","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib351","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1139\/cjpp-2015-0135","article-title":"Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis","volume":"94","author":"Khodeer","year":"2016","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib352","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10554-015-0589-y","article-title":"Effect of ischemic postconditioning on myocardial salvage in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the POST randomized trial","volume":"31","author":"Kim","year":"2015","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1124\/pharmrev.121.000348_bib353","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.jacc.2017.02.034","article-title":"Ticagrelor versus clopidogrel on myocardial infarct size in patients undergoing primary percutaneous coronary intervention","volume":"69","author":"Kim","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib354","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2009.11.032","article-title":"Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival","volume":"628","author":"Kim","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib355","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/CIRCRESAHA.109.209643","article-title":"Extracellular heat shock protein 60, cardiac myocytes, and apoptosis","volume":"105","author":"Kim","year":"2009","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib356","doi-asserted-by":"crossref","first-page":"H2152","DOI":"10.1152\/ajpheart.00326.2006","article-title":"Evidence for enhanced eNOS function in coronary microvessels during the second window of protection","volume":"292","author":"Kim","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib357","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.thromres.2020.01.004","article-title":"Effect of remote ischaemic conditioning on coagulation function as measured by whole blood impedance aggregometry and rotational thromboelastometry in off-pump coronary artery bypass surgery: a randomised controlled trial","volume":"187","author":"Kim","year":"2020","journal-title":"Thromb Res"},{"key":"10.1124\/pharmrev.121.000348_bib358","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1160\/TH10-11-0692","article-title":"Ischaemic cardiovascular mortality in patients with non-valvular atrial fibrillation according to CHADS2 score","volume":"105","author":"Kim","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.121.000348_bib359","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.RES.0000183735.09871.61","article-title":"A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation","volume":"97","author":"Kim","year":"2005","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib360","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/europace\/eur241","article-title":"Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options\u2014a report from the 3rd Atrial Fibrillation Competence NETwork\/European Heart Rhythm Association consensus conference","volume":"14","author":"Kirchhof","year":"2012","journal-title":"Europace"},{"key":"10.1124\/pharmrev.121.000348_bib361","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104731","article-title":"The role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo","volume":"9","author":"Kiss","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib5711870","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCRESAHA.118.312784","article-title":"Reflection of Cardioprotection by Remote Ischemic Perconditioning in Attenuated ST-Segment Elevation During Ongoing Coronary Occlusion in Pigs","volume":"122","author":"Kleinbongard","year":"2018","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib362","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00395-021-00876-6","article-title":"The platelet paradox of injury versus protection in myocardial infarction\u2014has it been overlooked?","volume":"116","author":"Kleinbongard","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib363","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.235713","article-title":"Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation","volume":"108","author":"Kleinbongard","year":"2011","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib364","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1111\/bph.14839","article-title":"Co-morbidities and co-medications as confounders of cardioprotection\u2014does it matter in the clinical setting?","volume":"177","author":"Kleinbongard","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib365","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41569-021-00632-2","article-title":"A fresh look at coronary microembolization","volume":"19","author":"Kleinbongard","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib2269699","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00395-022-00965-0","article-title":"Non-responsiveness to cardioprotection by ischaemic preconditioning in Ossabaw minipigs with genetic predisposition to, but without the phenotype of the metabolic syndrome","volume":"117","author":"Kleinbongard","year":"2022","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib800","article-title":"No sex-related differences in infarct size, no-reflow and protection by ischaemic preconditioning in G\u00f6ttingen minipigs","author":"Kleinbongard","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib366","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000441216","article-title":"Confounders of cardioprotection by remote ischemic preconditioning in patients undergoing coronary artery bypass grafting","volume":"133","author":"Kleinbongard","year":"2016","journal-title":"Cardiology"},{"key":"10.1124\/pharmrev.121.000348_bib367","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00395-017-0660-z","article-title":"STAT3 as a common signal of ischemic conditioning: a lesson on \u201crigor and reproducibility\u201d in preclinical studies on cardioprotection","volume":"113","author":"Kleinbongard","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib368","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00424-016-1922-6","article-title":"Cardioprotection by remote ischemic conditioning and its signal transduction","volume":"469","author":"Kleinbongard","year":"2017","journal-title":"Pflugers Arch"},{"key":"10.1124\/pharmrev.121.000348_bib369","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10557-013-6451-3","article-title":"Nitroglycerin does not interfere with protection by remote ischemic preconditioning in patients with surgical coronary revascularization under isoflurane anesthesia","volume":"27","author":"Kleinbongard","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/pharmrev.121.000348_bib370","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib371","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI107898","article-title":"The \u201cno-reflow\u201d phenomenon after temporary coronary occlusion in the dog","volume":"54","author":"Kloner","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.121.000348_bib372","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1161\/hc5001.100039","article-title":"Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2","volume":"104","author":"Kloner","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib373","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.97.11.1042","article-title":"Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B","volume":"97","author":"Kloner","year":"1998","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib374","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4161\/auto.18980","article-title":"Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury","volume":"8","author":"Kobayashi","year":"2012","journal-title":"Autophagy"},{"key":"10.1124\/pharmrev.121.000348_bib375","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pharmrev.121.000348_bib376","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/147323000603400203","article-title":"Amiodarone offsets the cardioprotective effects of ischaemic preconditioning against ischaemia\/reperfusion injury","volume":"34","author":"Koo","year":"2006","journal-title":"J Int Med Res"},{"key":"10.1124\/pharmrev.121.000348_bib377","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/joa3.12077","article-title":"Inflammation and atrial fibrillation: a comprehensive review","volume":"34","author":"Korantzopoulos","year":"2018","journal-title":"J Arrhythm"},{"key":"10.1124\/pharmrev.121.000348_bib378","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1399-6576.2011.02585.x","article-title":"Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol\u2014a clinical trial","volume":"56","author":"Kottenberg","year":"2012","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1124\/pharmrev.121.000348_bib379","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/aas.12278","article-title":"Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation","volume":"58","author":"Kottenberg","year":"2014","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1124\/pharmrev.121.000348_bib380","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1021\/acs.analchem.6b04912","article-title":"A nontargeted UHPLC-HRMS metabolomics pipeline for metabolite identification: application to cardiac remote ischemic preconditioning","volume":"89","author":"Kouassi Nzoughet","year":"2017","journal-title":"Anal Chem"},{"key":"10.1124\/pharmrev.121.000348_bib381","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/cvr\/cvab075","article-title":"Alternative strategies in cardiac preclinical research and new clinical trial formats","volume":"118","author":"Kreutzer","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib382","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/europace\/euaa030","article-title":"Subclinical atherosclerosis is associated with incident atrial fibrillation: a systematic review and meta-analysis","volume":"22","author":"Kristensen","year":"2020","journal-title":"Europace"},{"key":"10.1124\/pharmrev.121.000348_bib383","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12933-019-0872-7","article-title":"Impact of hyperglycemia on myocardial ischemia-reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes","volume":"18","author":"Kristiansen","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1124\/pharmrev.121.000348_bib384","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.RES.19.1.57","article-title":"Blood supply of the myocardium after temporary coronary occlusion","volume":"19","author":"Krug","year":"1966","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib385","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/joa3.12252","article-title":"Remote ischemic preconditioning and its role in the prevention of new onset atrial fibrillation post-cardiac surgery. A meta-analysis of randomized control trials","volume":"35","author":"Kumar","year":"2019","journal-title":"J Arrhythm"},{"key":"10.1124\/pharmrev.121.000348_bib386","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1582-4934.2011.01491.x","article-title":"The Akt1 isoform is an essential mediator of ischaemic preconditioning","volume":"16","author":"Kunuthur","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1124\/pharmrev.121.000348_bib387","doi-asserted-by":"crossref","first-page":"H1729","DOI":"10.1152\/ajpheart.00484.2009","article-title":"Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite","volume":"297","author":"Kupai","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib388","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1189\/jlb.72.3.455","article-title":"Molecular mechanisms of platelet-mediated leukocyte recruitment during myocardial reperfusion","volume":"72","author":"Kupatt","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1124\/pharmrev.121.000348_bib389","first-page":"617","article-title":"Effect of ischemic preconditioning on endothelial dysfunction and granulocyte adhesion in isolated guinea-pig hearts subjected to ischemia\/reperfusion","volume":"50","author":"Kurzelewski","year":"1999","journal-title":"J Physiol Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib390","doi-asserted-by":"crossref","first-page":"18682","DOI":"10.1038\/s41598-021-98058-w","article-title":"Mendelian randomization study on atrial fibrillation and cardiovascular disease subtypes","volume":"11","author":"Kwok","year":"2021","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000348_bib391","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.fertnstert.2011.07.1101","article-title":"High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection","volume":"96","author":"Kyrou","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1124\/pharmrev.121.000348_bib392","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1161\/CIRCRESAHA.109.213645","article-title":"Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females","volume":"106","author":"Lagranha","year":"2010","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib393","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12933-020-01066-9","article-title":"Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia\/reperfusion injury","volume":"19","author":"Lahnwong","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1124\/pharmrev.121.000348_bib394","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/ALN.0b013e318197ff62","article-title":"Desflurane-induced postconditioning is mediated by beta-adrenergic signaling: role of beta 1- and beta 2-adrenergic receptors, protein kinase A, and calcium\/calmodulin-dependent protein kinase II","volume":"110","author":"Lange","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1124\/pharmrev.121.000348_bib395","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.amjcard.2015.10.056","article-title":"Effect of remote ischemic preconditioning on platelet activation induced by coronary procedures","volume":"117","author":"Lanza","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib396","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14810","article-title":"Influence of strain, age, origin, and anesthesia on the cardioprotective efficacy by local and remote ischemic conditioning in an ex vivo rat model","volume":"9","author":"Lassen","year":"2021","journal-title":"Physiol Rep"},{"key":"10.1124\/pharmrev.121.000348_bib397","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00395-021-00856-w","article-title":"Cardioprotection by remote ischemic conditioning is transferable by plasma and mediated by extracellular vesicles","volume":"116","author":"Lassen","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib398","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jcms.2018.04.010","article-title":"Virtual histology uncertainty in synchrotron x-ray micro-computed tomography evaluation","volume":"46","author":"Lauridsen","year":"2018","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1124\/pharmrev.121.000348_bib399","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.yjmcc.2009.01.003","article-title":"Multiple protective pathways against reperfusion injury: a SAFE path without Aktion?","volume":"46","author":"Lecour","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib400","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00395-021-00893-5","article-title":"IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action","volume":"116","author":"Lecour","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib401","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1139\/cjpp-2012-0414","article-title":"Impact of age and sex on response to ischemic preconditioning in the rat heart: differential role of the PI3K-AKT pathway","volume":"91","author":"Ledvenyiova","year":"2013","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib402","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/pharmrev.121.000348_bib403","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/01.CIR.103.24.2935","article-title":"Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty","volume":"103","author":"Leesar","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib404","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00395-002-0363-x","article-title":"Do neutrophils contribute to myocardial reperfusion injury?","volume":"97","author":"Lefer","year":"2002","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib405","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/1074248411414155","article-title":"Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation","volume":"16","author":"Lefer","year":"2011","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1124\/pharmrev.121.000348_bib406","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/bja\/aev451","article-title":"The mechanisms of cardio-protective effects of desflurane and sevoflurane at the time of reperfusion: anaesthetic post-conditioning potentially translatable to humans?","volume":"116","author":"Lemoine","year":"2016","journal-title":"Br J Anaesth"},{"key":"10.1124\/pharmrev.121.000348_bib407","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/eurheartj\/ehl501","article-title":"Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?","volume":"28","author":"Lerman","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib408","first-page":"H1544","article-title":"Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria","volume":"273","author":"Lesnefsky","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib409","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/cvr\/cvs099","article-title":"The role of calpains in myocardial remodelling and heart failure","volume":"96","author":"Letavernier","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib410","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jacc.2015.10.005","volume":"67","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib411","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00395-014-0423-z","article-title":"MicroRNA-144 is a circulating effector of remote ischemic preconditioning","volume":"109","author":"Li","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib412","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCRESAHA.119.316364","article-title":"Inflammasomes and proteostasis novel molecular mechanisms associated with atrial fibrillation","volume":"127","author":"Li","year":"2020","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib413","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1097\/MJT.0000000000000370","article-title":"Effects of first high-dose atorvastatin loading in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention","volume":"25","author":"Li","year":"2018","journal-title":"Am J Ther"},{"key":"10.1124\/pharmrev.121.000348_bib414","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3892\/etm.2015.2782","article-title":"Pharmacological preconditioning and postconditioning with nicorandil attenuates ischemia\/reperfusion-induced myocardial necrosis and apoptosis in hypercholesterolemic rats","volume":"10","author":"Li","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1124\/pharmrev.121.000348_bib415","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4070\/kcj.2015.0295","article-title":"AT1 receptor modulator attenuates the hypercholesterolemia-induced impairment of the myocardial ischemic post-conditioning benefits","volume":"47","author":"Li","year":"2017","journal-title":"Korean Circ J"},{"key":"10.1124\/pharmrev.121.000348_bib416","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00702.2020","article-title":"Coronary heart disease and atrial fibrillation: a vicious cycle","volume":"320","author":"Liang","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib417","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jacc.2021.12.017","article-title":"Inflammation, aging, and cardiovascular disease: JACC review topic of the week","volume":"79","author":"Liberale","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib418","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2017.11.119","article-title":"Fatal attraction\u2014a brief pathophysiology of the interaction between atrial fibrillation and myocardial ischemia","volume":"254","author":"Lieder","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib419","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14146","article-title":"Sex is no determinant of cardioprotection by ischemic preconditioning in rats, but ischemic\/reperfused tissue mass is for remote ischemic preconditioning","volume":"7","author":"Lieder","year":"2019","journal-title":"Physiol Rep"},{"key":"10.1124\/pharmrev.121.000348_bib420","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/CIRCRESAHA.118.313859","article-title":"Vago-splenic axis in signal transduction of remote ischemic preconditioning in pigs and rats","volume":"123","author":"Lieder","year":"2018","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib421","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00395-010-0099-y","article-title":"The neural and humoral pathways in remote limb ischemic preconditioning","volume":"105","author":"Lim","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib422","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacbts.2018.10.002","article-title":"SGLT2 inhibitor, canagliflozin, attenuates myocardial infarction in the diabetic and nondiabetic heart","volume":"4","author":"Lim","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1124\/pharmrev.121.000348_bib423","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/j.1476-5381.2011.01691.x","article-title":"Cyclosporin variably and inconsistently reduces infarct size in experimental models of reperfused myocardial infarction: a systematic review and meta-analysis","volume":"165","author":"Lim","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib424","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"Lincoff","year":"2007","journal-title":"JAMA"},{"key":"10.1124\/pharmrev.121.000348_bib425","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/01.CIR.84.1.350","article-title":"Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart","volume":"84","author":"Liu","year":"1991","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib426","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/01.RES.78.3.443","article-title":"Synergistic modulation of ATP-sensitive K+ currents by protein kinase C and adenosine. Implications for ischemic preconditioning","volume":"78","author":"Liu","year":"1996","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib427","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0022-2828(95)90038-1","article-title":"Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts","volume":"27","author":"Liu","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib428","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1006\/jmcc.1994.1078","article-title":"Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium","volume":"26","author":"Liu","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib429","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.hrthm.2019.01.013","article-title":"Calcium\/calmodulin-dependent protein kinase II causes atrial structural remodeling associated with atrial fibrillation and heart failure","volume":"16","author":"Liu","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1124\/pharmrev.121.000348_bib430","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/AC.71.5.3167504","article-title":"Remote ischaemic preconditioning reduces myocardial ischaemic reperfusion injury in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"71","author":"Liu","year":"2016","journal-title":"Acta Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib431","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/eurheartj\/ehq464","article-title":"Abnormal calcium handling in atrial fibrillation is linked to up-regulation of adenosine A2A receptors","volume":"32","author":"Llach","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib432","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00395-020-0812-4","article-title":"Metoprolol blunts the time-dependent progression of infarct size","volume":"115","author":"Lobo-Gonzalez","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib433","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11010-020-03812-9","article-title":"Long-chain free fatty acids inhibit ischaemic preconditioning of the isolated rat heart","volume":"473","author":"Lochner","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/pharmrev.121.000348_bib434","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF00788867","article-title":"Substrate effects on sarcolemmal permeability in the normoxic and hypoxic perfused rat heart","volume":"91","author":"Lochner","year":"1996","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib435","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/CIRCINTERVENTIONS.112.968388","article-title":"Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia","volume":"5","author":"L\u00f8nborg","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1124\/pharmrev.121.000348_bib436","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ejechocard\/jer296","article-title":"Influence of pre-infarction angina, collateral flow, and pre-procedural TIMI flow on myocardial salvage index by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction","volume":"13","author":"L\u00f8nborg","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1124\/pharmrev.121.000348_bib437","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/eurheartj\/ehr309","article-title":"Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction","volume":"33","author":"L\u00f8nborg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib438","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/bcp.12469","article-title":"Effects of factor Xa on the expression of proteins in femoral arteries from type 2 diabetic patients","volume":"78","author":"L\u00f3pez-Farr\u00e9","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib439","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048513","article-title":"Pre-infarction angina and outcomes in non-ST-segment elevation myocardial infarction: data from the RICO survey","volume":"7","author":"Lorgis","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib440","first-page":"234","article-title":"Microarray analysis reveals a potential role of lncRNA expression in remote ischemic preconditioning in myocardial ischemia-reperfusion injury","volume":"13","author":"Lou","year":"2021","journal-title":"Am J Transl Res"},{"key":"10.1124\/pharmrev.121.000348_bib441","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0735-1097(01)01701-6","article-title":"A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction","volume":"39","author":"Loubeyre","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib442","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/CIRCULATIONAHA.106.653782","article-title":"Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism","volume":"116","author":"Loukogeorgakis","year":"2007","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib443","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbadis.2013.10.006","article-title":"Toll-like receptor 3 plays a role in myocardial infarction and ischemia\/reperfusion injury","volume":"1842","author":"Lu","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.121.000348_bib444","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12576-016-0477-9","article-title":"Elevated C-type natriuretic peptide elicits exercise preconditioning-induced cardioprotection against myocardial injury probably via the up-regulation of NPR-B","volume":"67","author":"Lu","year":"2017","journal-title":"J Physiol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib445","doi-asserted-by":"crossref","first-page":"500","DOI":"10.6061\/clinics\/2015(07)07","article-title":"Olmesartan restores the protective effect of remote ischemic perconditioning against myocardial ischemia\/reperfusion injury in spontaneously hypertensive rats","volume":"70","author":"Lu","year":"2015","journal-title":"Clinics (S\u00e3o Paulo)"},{"key":"10.1124\/pharmrev.121.000348_bib446","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3892\/etm.2015.2373","article-title":"Protective effect of olmesartan against cardiac ischemia\/reperfusion injury in spontaneously hypertensive rats","volume":"9","author":"Lu","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1124\/pharmrev.121.000348_bib447","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1213\/ANE.0000000000002676","article-title":"Differential effects of anesthetics and opioid receptor activation on cardioprotection elicited by reactive oxygen species-mediated postconditioning in Sprague-Dawley rat hearts","volume":"126","author":"Lucchinetti","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1124\/pharmrev.121.000348_bib448","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/cvr\/cvy231","article-title":"microRNA-423-3p exosomes derived from cardiac fibroblasts mediates the cardioprotective effects of ischaemic post-conditioning","volume":"115","author":"Luo","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib449","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/europace\/euaa234","article-title":"Long-term impact of the burden of new-onset atrial fibrillation in patients with acute myocardial infarction: results from the NOAFCAMI-SH registry","volume":"23","author":"Luo","year":"2021","journal-title":"Europace"},{"key":"10.1124\/pharmrev.121.000348_bib450","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/ehf2.12872","article-title":"Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure","volume":"7","author":"Luo","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1124\/pharmrev.121.000348_bib451","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejcts.2007.11.010","article-title":"Effect of ischemic postconditioning in adult valve replacement","volume":"33","author":"Luo","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1124\/pharmrev.121.000348_bib452","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.celrep.2015.06.017","article-title":"The mitochondrial calcium uniporter matches energetic supply with cardiac workload during stress and modulates permeability transition","volume":"12","author":"Luongo","year":"2015","journal-title":"Cell Rep"},{"key":"10.1124\/pharmrev.121.000348_bib453","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1038\/srep07071","article-title":"Ventricular hypertrophy blocked delayed anesthetic cardioprotection in rats by alteration of iNOS\/COX-2 signaling","volume":"4","author":"Ma","year":"2014","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000348_bib454","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/SHK.0000000000000737","article-title":"Hypercholesterolemia abrogates remote ischemic preconditioning-induced cardioprotection: role of reperfusion injury salvage kinase signals","volume":"47","author":"Ma","year":"2017","journal-title":"Shock"},{"key":"10.1124\/pharmrev.121.000348_bib455","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/SHK.0b013e3182a0674b","article-title":"Hypertrophied myocardium is refractory to sevoflurane-induced protection with alteration of reperfusion injury salvage kinase\/glycogen synthase kinase 3\u03b2 signals","volume":"40","author":"Ma","year":"2013","journal-title":"Shock"},{"key":"10.1124\/pharmrev.121.000348_bib456","series-title":"REmote preconditioning for Protection Against Ischaemia-Reperfusion in renal transplantation (REPAIR): a multicentre, multinational, double-blind, factorial designed randomised controlled trial","author":"MacAllister","year":"2015"},{"key":"10.1124\/pharmrev.121.000348_bib457","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/B:CARD.0000029028.75316.5e","article-title":"Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide","volume":"18","author":"Maddock","year":"2004","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/pharmrev.121.000348_bib458","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijcard.2014.12.159","article-title":"Sustained blood pressure lowering effect of twice daily remote ischemic conditioning sessions in a normotensive\/prehypertensive subject","volume":"182","author":"Madias","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib459","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.freeradbiomed.2021.04.034","article-title":"Systematic review and network analysis of microRNAs involved in cardioprotection against myocardial ischemia\/reperfusion injury and infarction: involvement of redox signalling","volume":"172","author":"Makkos","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/pharmrev.121.000348_bib460","first-page":"H1541","article-title":"Microvascular compression during myocardial ischemia: mechanistic basis for no-reflow phenomenon","volume":"266","author":"Manciet","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib461","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.amjcard.2015.09.016","article-title":"Myocardial infarct size in patients on long-term statin therapy undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"116","author":"Marenzi","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib462","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.molmed.2020.10.002","article-title":"Intercellular communication in the heart: therapeutic opportunities for cardiac ischemia","volume":"27","author":"Martins-Marques","year":"2021","journal-title":"Trends Mol Med"},{"key":"10.1124\/pharmrev.121.000348_bib463","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.020973","article-title":"Post-ST-segment-elevation myocardial infarction platelet reactivity is associated with the extent of microvascular obstruction and infarct size as determined by cardiac magnetic resonance imaging","volume":"11","author":"Massalha","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pharmrev.121.000348_bib464","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.yjmcc.2008.10.008","article-title":"Proteomic and metabolomic analysis of cardioprotection: interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts","volume":"46","author":"Mayr","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib465","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-030-11488-6_8","article-title":"Dyslipidemia in ischemia\/reperfusion injury","volume":"1127","author":"Mazo","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pharmrev.121.000348_bib466","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105361","article-title":"A randomized pilot trial of remote ischemic preconditioning in heart failure with reduced ejection fraction","volume":"9","author":"McDonald","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib467","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib468","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00395-019-0760-z","article-title":"Molecular pathways involved in the cardioprotective effects of intravenous statin administration during ischemia","volume":"115","author":"Mendieta","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib469","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2020.01.042","article-title":"Intravenous statin administration during myocardial infarction compared with oral post-infarct administration","volume":"75","author":"Mendieta","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib470","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1212\/WNL.0b013e318271f76a","article-title":"Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis","volume":"79","author":"Meng","year":"2012","journal-title":"Neurology"},{"key":"10.1124\/pharmrev.121.000348_bib471","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.RES.0000260203.55077.61","article-title":"A role for caspase-1 in heart failure","volume":"100","author":"Merkle","year":"2007","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib472","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00395-013-0383-8","article-title":"Postconditioning attenuates no-reflow in STEMI patients","volume":"108","author":"Mewton","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib473","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa1413579","article-title":"A multicenter trial of remote ischemic preconditioning for heart surgery","volume":"373","author":"Meybohm","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib474","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.eurheartj.a061845","article-title":"Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial","volume":"6","year":"1985","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib475","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib476","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/cvr\/cvp157","article-title":"Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake","volume":"83","author":"Miro-Casas","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib477","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.RES.76.1.73","article-title":"Preconditioning of isolated rat heart is mediated by protein kinase C","volume":"76","author":"Mitchell","year":"1995","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib478","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0253-7613.174545","article-title":"Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart","volume":"48","author":"Mittal","year":"2016","journal-title":"Indian J Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib479","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1161\/01.CIR.103.25.3111","article-title":"Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide","volume":"103","author":"Mocanu","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib480","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s11033-021-06987-6","article-title":"Alpha-lipoic acid preconditioning plus ischemic postconditioning provides additional protection against myocardial reperfusion injury of diabetic rats: modulation of autophagy and mitochondrial function","volume":"49","author":"Mokhtari","year":"2022","journal-title":"Mol Biol Rep"},{"key":"10.1124\/pharmrev.121.000348_bib481","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/HJH.0000000000000826","article-title":"Increased myocardial vulnerability to ischemia-reperfusion injury in the presence of left ventricular hypertrophy","volume":"34","author":"M\u00f8lgaard","year":"2016","journal-title":"J Hypertens"},{"key":"10.1124\/pharmrev.121.000348_bib482","doi-asserted-by":"crossref","first-page":"104521","DOI":"10.1016\/j.phrs.2019.104521","article-title":"The role of amiodarone in contemporary management of complex cardiac arrhythmias","volume":"151","author":"Mujovi\u0107","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.121.000348_bib483","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/bja\/68.6.613","article-title":"The antioxidant potential of propofol (2,6-diisopropylphenol)","volume":"68","author":"Murphy","year":"1992","journal-title":"Br J Anaesth"},{"key":"10.1124\/pharmrev.121.000348_bib484","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.yjmcc.2018.06.007","article-title":"Cardioprotection by nicotinamide mononucleotide (NMN): involvement of glycolysis and acidic pH","volume":"121","author":"Nadtochiy","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib485","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1253\/circrep.CR-19-0117","article-title":"Cardioprotective effects of rivaroxaban on cardiac remodeling after experimental myocardial infarction in mice","volume":"2","author":"Nakanishi","year":"2020","journal-title":"Circ Rep"},{"key":"10.1124\/pharmrev.121.000348_bib486","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCRESAHA.120.316363","article-title":"Molecular basis of atrial fibrillation pathophysiology and therapy: a translational perspective","volume":"127","author":"Nattel","year":"2020","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib487","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/01.CIR.96.2.599","article-title":"Inhibition of sarcolemmal Na+,K+-ATPase activity reduces the infarct size-limiting effect of preconditioning in rabbit hearts","volume":"96","author":"Nawada","year":"1997","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib488","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.metabol.2017.04.008","article-title":"Acute detachment of hexokinase II from mitochondria modestly increases oxygen consumption of the intact mouse heart","volume":"72","author":"Nederlof","year":"2017","journal-title":"Metabolism"},{"key":"10.1124\/pharmrev.121.000348_bib489","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/heartjnl-2019-314952","article-title":"Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction","volume":"106","author":"Nepper-Christensen","year":"2020","journal-title":"Heart"},{"key":"10.1124\/pharmrev.121.000348_bib490","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004823","article-title":"Left ventricular hypertrophy is associated with increased infarct size and decreased myocardial salvage in patients With ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"6","author":"Nepper-Christensen","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pharmrev.121.000348_bib491","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/cdd.2016.46","article-title":"RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury","volume":"23","author":"Newton","year":"2016","journal-title":"Cell Death Differ"},{"key":"10.1124\/pharmrev.121.000348_bib492","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1253\/circj.CJ-14-0194","article-title":"Protective effect of pre-infarction angina on microvascular obstruction after primary percutaneous coronary intervention is blunted in humans by cardiovascular risk factors","volume":"78","author":"Niccoli","year":"2014","journal-title":"Circ J"},{"key":"10.1124\/pharmrev.121.000348_bib493","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001965","article-title":"Prospective, multicenter, randomized, controlled pilot trial of peritoneal hypothermia in patients with ST-segment- elevation myocardial infarction","volume":"8","author":"Nichol","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1124\/pharmrev.121.000348_bib494","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/ars.2019.7923","article-title":"Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice Through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress","volume":"34","author":"Nikolaou","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/pharmrev.121.000348_bib495","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/CIRCULATIONAHA.110.972778","article-title":"Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion in a chronic canine model","volume":"123","author":"Nishida","year":"2011","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib496","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cardiores.2003.10.022","article-title":"Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection","volume":"61","author":"Nishino","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib497","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4244\/EIJ-D-21-00348","article-title":"A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial","volume":"17","author":"Noc","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1124\/pharmrev.121.000348_bib498","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/01.RES.0000190588.84680.34","article-title":"Discrepancies between nitroglycerin and NO-releasing drugs on mitochondrial oxygen consumption, vasoactivity, and the release of NO","volume":"97","author":"N\u00fa\u00f1ez","year":"2005","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib499","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11906-020-1017-9","article-title":"Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy","volume":"22","author":"Nwabuo","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"10.1124\/pharmrev.121.000348_bib500","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2012.03.045","article-title":"Helium-induced cardioprotection of healthy and hypertensive rat myocardium in vivo","volume":"684","author":"Oei","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib501","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCRESAHA.120.317710","article-title":"MTORC1-regulated metabolism controlled by TSC2 limits cardiac reperfusion injury","volume":"128","author":"Oeing","year":"2021","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib502","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.cell.2016.02.006","article-title":"EGLN1 inhibition and rerouting of \u03b1-ketoglutarate suffice for remote ischemic protection","volume":"164","author":"Olenchock","year":"2016","journal-title":"Cell"},{"key":"10.1124\/pharmrev.121.000348_bib503","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.93.4.656","article-title":"ATP-dependent potassium channel in rat cardiomyocytes is blocked by lidocaine. Possible impact on the antiarrhythmic action of lidocaine","volume":"93","author":"Olschewski","year":"1996","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib504","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.3390\/ijms20163972","article-title":"Targeting mitochondrial fission using Mdivi-1 in a clinically relevant large animal model of acute myocardial infarction: a pilot study","volume":"20","author":"Ong","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib505","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-5793(03)00006-1","article-title":"Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study","volume":"536","author":"Onody","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1124\/pharmrev.121.000348_bib506","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cvr\/cvw007","article-title":"Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation","volume":"109","author":"Opacic","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib507","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.118.313777","article-title":"Myonectin is an exercise-induced myokine that protects the heart from ischemia-reperfusion injury","volume":"123","author":"Otaka","year":"2018","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib508","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jacc.2015.10.081","article-title":"Cyclosporine A in reperfused myocardial infarction: the multicenter, controlled, open-label CYCLE Trial","volume":"67","author":"Ottani","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib509","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.CIR.0000112575.66565.84","article-title":"Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice","volume":"109","author":"Oyama","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib510","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-017-0628-1","article-title":"Effects of hypoglycemia on myocardial susceptibility to ischemia-reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes","volume":"16","author":"P\u00e6lestik","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1124\/pharmrev.121.000348_bib511","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2459\/JCM.0000000000000435","article-title":"Hypertension, hypertrophy, and reperfusion injury","volume":"18","author":"Pagliaro","year":"2017","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1124\/pharmrev.121.000348_bib512","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1111\/jcmm.14586","article-title":"PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia\/reperfusion injury: benefits beyond lipid-lowering effects","volume":"23","author":"Palee","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1124\/pharmrev.121.000348_bib513","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1016\/j.amjmed.2020.03.034","article-title":"The network medicine imperative and the need for an international network medicine consortium","volume":"133","author":"Parini","year":"2020","journal-title":"Am J Med"},{"key":"10.1124\/pharmrev.121.000348_bib514","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijcard.2009.07.013","article-title":"Efficacy of intracoronary administration of a short-acting \u03b2-blocker landiolol during reperfusion in pigs","volume":"146","author":"Park","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib515","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11306-017-1303-y","article-title":"Untargeted metabolomics analysis of ischemia-reperfusion-injured hearts ex vivo from sedentary and exercise-trained rats","volume":"14","author":"Parry","year":"2018","journal-title":"Metabolomics"},{"key":"10.1124\/pharmrev.121.000348_bib516","article-title":"Extent of mitochondrial hexokinase II dissociation during ischemia correlates with mitochondrial cytochrome c release, reactive oxygen species production, and infarct size on reperfusion","volume":"2","author":"Pasdois","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pharmrev.121.000348_bib517","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.117.027575","volume":"136","author":"Pasupathy","year":"2017","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib518","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jacc.2006.06.061","volume":"48","author":"Patti","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib519","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jacc.2007.02.025","article-title":"Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial","volume":"49","author":"Patti","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib520","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00395-021-00852-0","article-title":"Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response","volume":"116","author":"Pearce","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib521","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1161\/01.CIR.81.6.1921","article-title":"Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries","volume":"81","author":"Pearson","year":"1990","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib522","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11892-016-0728-4","article-title":"Safety and tolerability of glucagon-like peptide-1 receptor agonists utilizing data from the exenatide clinical trial development program","volume":"16","author":"Peng","year":"2016","journal-title":"Curr Diab Rep"},{"key":"10.1124\/pharmrev.121.000348_bib523","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9219825","article-title":"Ticagrelor conditioning effects are not additive to cardioprotection induced by direct NLRP3 inflammasome inhibition: role of RISK, NLRP3, and redox cascades","volume":"2020","author":"Penna","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1124\/pharmrev.121.000348_bib524","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00395-006-0584-5","article-title":"Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation","volume":"101","author":"Penna","year":"2006","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib525","first-page":"146","article-title":"A TRICk to improve the effectiveness of RIC: role of limb temperature in enhancing the effectiveness of remote ischemic conditioning","volume":"11","author":"Penna","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1124\/pharmrev.121.000348_bib526","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00395-008-0762-8","article-title":"Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender","volume":"104","author":"Penna","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib527","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00395-009-0075-6","article-title":"Effects of a protocol of ischemic postconditioning and\/or captopril in hearts of normotensive and hypertensive rats","volume":"105","author":"Penna","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib528","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11010-016-2677-2","article-title":"Ischemic postconditioning confers cardioprotection and prevents reduction of Trx-1 in young mice, but not in middle-aged and old mice","volume":"415","author":"Perez","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/pharmrev.121.000348_bib529","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/cvr\/cvx070","article-title":"Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart","volume":"113","author":"Perrino","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib530","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvaa155","article-title":"Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart","volume":"117","author":"Perrino","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib531","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.CIR.57.6.1091","article-title":"Reduction of enzyme levels by propranolol after acute myocardial infarction","volume":"57","author":"Peter","year":"1978","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib532","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5596590","article-title":"Remote and anesthetic-induced myocardial preconditioning is preserved in atherosclerotic LDL receptor-\/- mice in vivo","volume":"2021","author":"Petermichl","year":"2021","journal-title":"Cardiovasc Ther"},{"key":"10.1124\/pharmrev.121.000348_bib533","doi-asserted-by":"crossref","first-page":"11206","DOI":"10.1038\/s41598-019-47474-0","article-title":"Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice","volume":"9","author":"Pham","year":"2019","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000348_bib534","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cardiores.2006.11.003","article-title":"Ouabain triggers preconditioning through activation of the Na+,K+-ATPase signaling cascade in rat hearts","volume":"73","author":"Pierre","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib535","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJMoa071142","article-title":"Effect of cyclosporine on reperfusion injury in acute myocardial infarction","volume":"359","author":"Piot","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib536","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0008-6363(98)00033-9","article-title":"A fresh look at reperfusion injury","volume":"38","author":"Piper","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib537","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jss.2004.12.009","article-title":"Is the preconditioning threshold different in females?","volume":"125","author":"Pitcher","year":"2005","journal-title":"J Surg Res"},{"key":"10.1124\/pharmrev.121.000348_bib538","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2014.03.014","article-title":"Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction)","volume":"63","author":"Pizarro","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib539","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/ejcts\/ezac029","article-title":"Editorial comments on \u201cEffects of ischaemic postconditioning in aortic valve replacement: a multicenter randomized controlled trial.\u201d","volume":"61","author":"Podesser","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1124\/pharmrev.121.000348_bib540","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12968-020-00638-8","article-title":"Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy)","volume":"22","author":"Podlesnikar","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1124\/pharmrev.121.000348_bib541","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1160\/TH09-03-0165","article-title":"Protective effect of ischaemic preconditioning on ischaemia\/reperfusion-induced microvascular obstruction determined by on-line measurements of coronary pressure and blood flow in pigs","volume":"103","author":"Posa","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1124\/pharmrev.121.000348_bib542","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064093","article-title":"Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation","volume":"8","author":"Povlsen","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib0937725","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCRESAHA.121.320717","article-title":"Ischemia-Selective Cardioprotection by Malonate for Ischemia\/Reperfusion Injury","volume":"131","author":"Prag","year":"2022","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib543","first-page":"227","article-title":"Extracellular vesicles - mediating and delivering cardioprotection in acute myocardial infarction and heart failure","volume":"3","author":"Prakash","year":"2020","journal-title":"Cond Med"},{"key":"10.1124\/pharmrev.121.000348_bib544","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00395-013-0400-y","article-title":"The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction","volume":"109","author":"Prunier","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib545","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00395-017-0658-6","article-title":"Effect of long-term remote ischemic conditioning in patients with chronic ischemic heart failure","volume":"112","author":"Pryds","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib546","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jacc.2007.11.070","article-title":"Aging mouse hearts are refractory to infarct size reduction with post-conditioning","volume":"51","author":"Przyklenk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib547","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/ars.2010.3343","article-title":"Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes","volume":"14","author":"Przyklenk","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/pharmrev.121.000348_bib548","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/CIRCRESAHA.109.200378","article-title":"Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia\/reperfusion injury by suppressed autophagy and increased cell death","volume":"105","author":"Qian","year":"2009","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib549","doi-asserted-by":"crossref","first-page":"667961","DOI":"10.3389\/fphys.2021.667961","article-title":"Sex and response to cardioprotective conditioning maneuvers","volume":"12","author":"Querio","year":"2021","journal-title":"Front Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib550","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2021.02.030","article-title":"Exercise preconditioning as a cardioprotective phenotype","volume":"148","author":"Quindry","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib551","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fphar.2018.00238","article-title":"Efficacy and safety of cyclosporine in acute myocardial infarction: a systematic review and meta-analysis","volume":"9","author":"Rahman","year":"2018","journal-title":"Front Pharmacol"},{"issue":"11, Suppl","key":"10.1124\/pharmrev.121.000348_bib552","first-page":"S53","article-title":"Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?","volume":"122","author":"Rahman","year":"2010","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib553","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2337\/dc12-1495","article-title":"Effect of hypoglycemic agents on ischemic preconditioning in patients with type 2 diabetes and symptomatic coronary artery disease","volume":"36","author":"Rahmi","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1124\/pharmrev.121.000348_bib554","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1538-7836.2006.02028.x","article-title":"Thrombin generation during reperfusion after coronary artery bypass surgery associates with postoperative myocardial damage","volume":"4","author":"Raivio","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.121.000348_bib555","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.athoracsur.2008.12.097","article-title":"Thrombin in myocardial ischemia-reperfusion during cardiac surgery","volume":"88","author":"Raivio","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1124\/pharmrev.121.000348_bib556","doi-asserted-by":"crossref","first-page":"E2420","DOI":"10.1073\/pnas.1621047114","article-title":"Myocardial aging as a T-cell-mediated phenomenon","volume":"114","author":"Ramos","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.121.000348_bib557","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCRESAHA.114.303822","article-title":"Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning","volume":"114","author":"Rassaf","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib558","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/CIRCULATIONAHA.111.029223","article-title":"Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins","volume":"124","author":"Reilly","year":"2011","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib559","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/dom.13002","article-title":"Relationship between diabetes and ischaemic injury among patients with revascularized ST-elevation myocardial infarction","volume":"19","author":"Reinstadler","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pharmrev.121.000348_bib560","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ehjci\/jey101","article-title":"Intramyocardial haemorrhage and prognosis after ST-elevation myocardial infarction","volume":"20","author":"Reinstadler","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1124\/pharmrev.121.000348_bib561","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCINTERVENTIONS.112.973164","article-title":"Preinfarction angina reduces infarct size in ST-elevation myocardial infarction treated with percutaneous coronary intervention","volume":"6","author":"Reiter","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1124\/pharmrev.121.000348_bib562","doi-asserted-by":"crossref","first-page":"H432","DOI":"10.1152\/ajpheart.00738.2016","article-title":"Metabolism and acetylation contribute to leucine-mediated inhibition of cardiac glucose uptake","volume":"313","author":"Renguet","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib563","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ncpcardio0047","article-title":"Ischemic preconditioning and preinfarction angina in the clinical arena","volume":"1","author":"Rezkalla","year":"2004","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1124\/pharmrev.121.000348_bib564","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/cells9010252","article-title":"PPAR\u03b3-independent side effects of thiazolidinediones on mitochondrial redox state in rat isolated hearts","volume":"9","author":"Riess","year":"2020","journal-title":"Cells"},{"key":"10.1124\/pharmrev.121.000348_bib565","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.rinim.2013.11.002","article-title":"IL-6 signalling in patients with acute ST-elevation myocardial infarction","volume":"4","author":"Ritschel","year":"2013","journal-title":"Results Immunol"},{"key":"10.1124\/pharmrev.121.000348_bib566","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00005344-200110000-00002","article-title":"Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters assessed during reperfusion in isolated rat hearts","volume":"38","author":"Rochetaing","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib567","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/01.RES.0000230315.56904.de","article-title":"Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection","volume":"99","author":"Rodriguez-Sinovas","year":"2006","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib568","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.jacc.2016.03.522","article-title":"Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention","volume":"67","author":"Roolvink","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib569","doi-asserted-by":"crossref","first-page":"H1825","DOI":"10.1152\/ajpheart.495.2008","article-title":"Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation","volume":"295","author":"Rork","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib570","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12265-018-9819-8","article-title":"Mirabegron, a clinically approved \u03b23 adrenergic receptor agonist, does not reduce infarct size in a swine model of reperfused myocardial infarction","volume":"11","author":"Rossello","year":"2018","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1124\/pharmrev.121.000348_bib571","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00395-017-0657-7","article-title":"The role of PI3K\u03b1 isoform in cardioprotection","volume":"112","author":"Rossello","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib572","doi-asserted-by":"crossref","first-page":"20290","DOI":"10.1038\/s41598-019-56613-6","article-title":"CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): a multicenter preclinical network for testing reproducibility in cardiovascular interventions","volume":"9","author":"Rossello","year":"2019","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000348_bib573","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.3390\/ijms22052519","article-title":"Pharmacological conditioning of the heart: an update on experimental developments and clinical implications","volume":"22","author":"Roth","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib574","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00395-012-0275-3","article-title":"Cardioprotection by clopidogrel in acute ST-elevated myocardial infarction patients: a retrospective analysis","volume":"107","author":"Roubille","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib575","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","article-title":"Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis","volume":"24","author":"Ruddox","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib576","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.121.000348_bib577","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1111\/bph.14951","article-title":"Ageing, sex, and cardioprotection","volume":"177","author":"Ruiz-Meana","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib578","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/cvr\/cvaa132","article-title":"Cardiomyocyte ageing and cardioprotection: consensus document from the ESC working groups cell biology of the heart and myocardial function","volume":"116","author":"Ruiz-Meana","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib579","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.118.035869","article-title":"Ryanodine receptor glycation favors mitochondrial damage in the senescent heart","volume":"139","author":"Ruiz-Meana","year":"2019","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib580","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.yjmcc.2014.01.001","article-title":"Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol","volume":"68","author":"Ruiz-Meana","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib581","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1113\/EP088024","article-title":"Chronic type 2 but not type 1 diabetes impairs myocardial ischaemic tolerance and preconditioning in C57Bl\/6 mice","volume":"104","author":"Russell","year":"2019","journal-title":"Exp Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib582","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12933-017-0550-6","article-title":"Platelets, diabetes and myocardial ischemia\/reperfusion injury","volume":"16","author":"Russo","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1124\/pharmrev.121.000348_bib583","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0735-1097(91)90620-O","article-title":"Pharmacokinetic analysis of coronary venous retroinfusion: a comparison with anterograde coronary artery drug administration using metoprolol as a tracer","volume":"18","author":"Ryd\u00e9n","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib584","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2020.05.011","article-title":"Infarct size following loading with Ticagrelor\/Prasugrel versus Clopidogrel in ST-segment elevation myocardial infarction","volume":"314","author":"Sabbah","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib585","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1253\/circj.CJ-14-1218","article-title":"Glucose fluctuations aggravate cardiac susceptibility to ischemia\/reperfusion injury by modulating MicroRNAs expression","volume":"80","author":"Saito","year":"2016","journal-title":"Circ J"},{"key":"10.1124\/pharmrev.121.000348_bib586","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10557-010-6275-3","article-title":"The role of \u03b2-adrenergic receptors in the cardioprotective effects of beta-preconditioning (\u03b2PC)","volume":"25","author":"Salie","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/pharmrev.121.000348_bib587","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbrc.2015.12.051","article-title":"NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective","volume":"469","author":"Sandanger","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pharmrev.121.000348_bib588","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvt091","article-title":"The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib589","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.yjmcc.2018.10.016","article-title":"Resistance exercise mediates remote ischemic preconditioning by limiting cardiac eNOS uncoupling","volume":"125","author":"Santana","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib590","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13293-021-00392-1","article-title":"Ischemic preconditioning protects the heart against ischemia-reperfusion injury in chronic kidney disease in both males and females","volume":"12","author":"S\u00e1rk\u00f6zy","year":"2021","journal-title":"Biol Sex Differ"},{"key":"10.1124\/pharmrev.121.000348_bib01243666","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"10.1124\/pharmrev.121.000348_bib591","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0022-5223(98)70018-2","article-title":"Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium","volume":"116","author":"Sawa","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1124\/pharmrev.121.000348_bib592","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/icvts\/ivt279","article-title":"Remote ischaemic preconditioning down-regulates kinin receptor expression in neutrophils of patients undergoing heart surgery","volume":"17","author":"Saxena","year":"2013","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1124\/pharmrev.121.000348_bib593","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12967-019-1881-8","article-title":"Acute canagliflozin treatment protects against in vivo myocardial ischemia-reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation","volume":"17","author":"Sayour","year":"2019","journal-title":"J Transl Med"},{"key":"10.1124\/pharmrev.121.000348_bib594","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijcard.2011.11.085","article-title":"Effect of pre-infarction angina on platelet reactivity in acute myocardial infarction","volume":"167","author":"Scalone","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib595","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ccd.29793","article-title":"Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI","volume":"99","author":"Scarsini","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1124\/pharmrev.121.000348_bib596","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1124\/jpet.110.167486","article-title":"TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition","volume":"333","author":"Schaller","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.121.000348_bib597","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijcard.2015.03.328","article-title":"Time-dependent effect of preinfarction angina pectoris and intermittent claudication on mortality following myocardial infarction: a Danish nationwide cohort study","volume":"187","author":"Schmidt","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib598","doi-asserted-by":"crossref","first-page":"H1481","DOI":"10.1152\/ajpheart.01089.2001","article-title":"Urocortin protects the heart from reperfusion injury via upregulation of p42\/p44 MAPK signaling pathway","volume":"283","author":"Schulman","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib3357277","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/CIRCRESAHA.122.321582","article-title":"Targeted Mito- and Cardioprotection by Malonate","volume":"131","author":"Schulz","year":"2022","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib599","doi-asserted-by":"crossref","first-page":"H2175","DOI":"10.1152\/ajpheart.2001.280.5.H2175","article-title":"Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs","volume":"280","author":"Schulz","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib600","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.98.10.1022","article-title":"Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin","volume":"98","author":"Schulz","year":"1998","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib601","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib602","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1038\/s41598-021-89149-9","article-title":"Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats","volume":"11","author":"Seefeldt","year":"2021","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000348_bib603","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088542","article-title":"Intermittent losartan administration triggers cardiac post-conditioning in isolated rat hearts: role of BK2 receptors","volume":"9","author":"Sgarra","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib604","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/cvr\/cvab139","article-title":"Extracellular histones are a target in myocardial ischaemia-reperfusion injury","volume":"118","author":"Shah","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib605","first-page":"3509","article-title":"Edoxaban improves atrial fibrillation and thromboembolism through regulation of the Wnt-\u03b2-induced PI3K\/ATK-activated protein C system","volume":"17","author":"Shan","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1124\/pharmrev.121.000348_bib606","doi-asserted-by":"crossref","first-page":"H237","DOI":"10.1152\/ajpheart.01192.2004","article-title":"Mitochondrial permeability transition pore as a target for cardioprotection in the human heart","volume":"289","author":"Shanmuganathan","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib607","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bbrc.2018.04.071","article-title":"Apixaban attenuates ischemia-induced myocardial fibrosis by inhibition of Gq\/PKC signaling","volume":"500","author":"Shi","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pharmrev.121.000348_bib608","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCRESAHA.120.318629","article-title":"GSDMD-mediated cardiomyocyte pyroptosis promotes myocardial I\/R injury","volume":"129","author":"Shi","year":"2021","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib609","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1124\/pharmrev.121.000348_bib610","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.114.015134","article-title":"Prevalence, clinical features, and prognosis of acute myocardial infarction attributable to coronary artery embolism","volume":"132","author":"Shibata","year":"2015","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib611","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jss.2008.08.010","article-title":"Remote ischemic preconditioning decreases adhesion and selectively modifies functional responses of human neutrophils","volume":"158","author":"Shimizu","year":"2010","journal-title":"J Surg Res"},{"key":"10.1124\/pharmrev.121.000348_bib612","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehu096","article-title":"Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)","volume":"35","author":"Siddiqi","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib613","doi-asserted-by":"crossref","first-page":"H871","DOI":"10.1152\/ajpheart.00293.2017","article-title":"Impact of electrical defibrillation on infarct size and no-reflow in pigs subjected to myocardial ischemia-reperfusion without and with ischemic conditioning","volume":"313","author":"Skyschally","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib614","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.yjmcc.2005.04.003","article-title":"Preinfarction angina: no interference of coronary microembolization with acute ischemic preconditioning","volume":"39","author":"Skyschally","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib615","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/01.RES.0000255031.15793.86","article-title":"Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction","volume":"100","author":"Skyschally","year":"2007","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib616","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10557-011-6300-1","article-title":"Reduction of myocardial infarct size by dronedarone in pigs\u2014a pleiotropic action?","volume":"25","author":"Skyschally","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/pharmrev.121.000348_bib617","doi-asserted-by":"crossref","first-page":"H159","DOI":"10.1152\/ajpheart.00152.2018","article-title":"Humoral transfer and intramyocardial signal transduction of protection by remote ischemic perconditioning in pigs, rats, and mice","volume":"315","author":"Skyschally","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib618","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cardiores.2004.04.003","article-title":"Coronary microembolization does not induce acute preconditioning against infarction in pigs-the role of adenosine","volume":"63","author":"Skyschally","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib619","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10557-010-6219-y","article-title":"Cyclosporine A at reperfusion reduces infarct size in pigs","volume":"24","author":"Skyschally","year":"2010","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/pharmrev.121.000348_bib620","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCRESAHA.108.186429","article-title":"Ischemic postconditioning in pigs: no causal role for RISK activation","volume":"104","author":"Skyschally","year":"2009","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib621","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehs434","article-title":"Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning","volume":"34","author":"Skyschally","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib622","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCRESAHA.114.302751","article-title":"Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery","volume":"114","author":"Slagsvold","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib623","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/eurheartj\/eht369","article-title":"Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention","volume":"35","author":"Sloth","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib624","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006923","article-title":"Impact of cardiovascular risk factors and medication use on the efficacy of remote ischaemic conditioning: post hoc subgroup analysis of a randomised controlled trial","volume":"5","author":"Sloth","year":"2015","journal-title":"BMJ Open"},{"key":"10.1124\/pharmrev.121.000348_bib8572475","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cvr\/cvx211","article-title":"Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology","volume":"114","author":"Sluijter","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib625","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/CIRCRESAHA.111.244962","article-title":"Disruption of hexokinase II-mitochondrial binding blocks ischemic preconditioning and causes rapid cardiac necrosis","volume":"108","author":"Smeele","year":"2011","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib626","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/bph.12994","article-title":"Noble gases as cardioprotectants - translatability and mechanism","volume":"172","author":"Smit","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib627","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10557-007-6035-1","article-title":"Necrostatin: a potentially novel cardioprotective agent?","volume":"21","author":"Smith","year":"2007","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/pharmrev.121.000348_bib628","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fphys.2020.00493","article-title":"Inhibition of adenosine pathway alters atrial electrophysiology and prevents atrial fibrillation","volume":"11","author":"Soattin","year":"2020","journal-title":"Front Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib629","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00210-021-02179-y","article-title":"Minocycline as heart conditioning agent in experimental type 2 diabetes mellitus - an antibacterial drug in heart protection","volume":"395","author":"Sobot","year":"2022","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib630","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0002-9149(62)90035-8","article-title":"Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report","volume":"9","author":"Sodi-Pallares","year":"1962","journal-title":"Am J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib631","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/CIRCULATIONAHA.117.028441","article-title":"Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)","volume":"136","author":"Soliman","year":"2017","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib632","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/CIRCULATIONAHA.114.014145","article-title":"Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"131","author":"Soliman","year":"2015","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib633","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11906-017-0777-3","article-title":"Antihypertensive therapies and left ventricular hypertrophy","volume":"19","author":"Soliman","year":"2017","journal-title":"Curr Hypertens Rep"},{"key":"10.1124\/pharmrev.121.000348_bib634","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","article-title":"Atrial fibrillation and the risk of myocardial infarction","volume":"174","author":"Soliman","year":"2014","journal-title":"JAMA Intern M"},{"key":"10.1124\/pharmrev.121.000348_bib635","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1365-201X.2003.01068.x","article-title":"Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice","volume":"177","author":"Song","year":"2003","journal-title":"Acta Physiol Scand"},{"key":"10.1124\/pharmrev.121.000348_bib636","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2017.08.073","article-title":"Effects of remote ischemic preconditioning in patients with concentric myocardial hypertrophy: a randomized, controlled trial with molecular insights","volume":"249","author":"Song","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib637","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.regpep.2007.10.001","article-title":"Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart","volume":"146","author":"Sonne","year":"2008","journal-title":"Regul Pept"},{"key":"10.1124\/pharmrev.121.000348_bib638","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.3390\/ijms20092140","article-title":"Effect of ischemic preconditioning and postconditioning on exosome-rich fraction microRNA levels, in relation with electrophysiological parameters and ventricular arrhythmia in experimental closed-chest reperfused myocardial infarction","volume":"20","author":"Spannbauer","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib639","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/cvr\/28.7.1025","article-title":"Ischaemic preconditioning protects hypertrophied myocardium","volume":"28","author":"Speechly-Dick","year":"1994","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib640","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/CIRCULATIONAHA.105.558122","article-title":"Postconditioning the human heart","volume":"112","author":"Staat","year":"2005","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib641","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCRESAHA.118.314500","article-title":"Combined intrahospital remote ischemic perconditioning and postconditioning improves clinical outcome in ST-elevation myocardial infarction","volume":"124","author":"Stiermaier","year":"2019","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib642","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00392-018-1273-8","article-title":"Impact of left ventricular hypertrophy on myocardial injury in patients with ST-segment elevation myocardial infarction","volume":"107","author":"Stiermaier","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib643","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018881","article-title":"Impact of morphine treatment with and without metoclopramide coadministration on myocardial and microvascular injury in acute myocardial infarction: insights from the randomized MonAMI Trial","volume":"10","author":"Stiermaier","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pharmrev.121.000348_bib644","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","article-title":"Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials","volume":"67","author":"Stone","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib645","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1582-4934.2012.01661.x","article-title":"Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia\/reperfusion injury: role of thioredoxin-interacting protein","volume":"17","author":"Su","year":"2013","journal-title":"J Cell Mol Med"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.121.000348_bib646","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/0267659111420607","article-title":"Cardioplegic strategies to protect the hypertrophic heart during cardiac surgery","volume":"26","author":"Suleiman","year":"2011","journal-title":"Perfusion"},{"key":"10.1124\/pharmrev.121.000348_bib647","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/cvr\/cvv044","article-title":"Ischaemic preconditioning preferentially increases protein S-nitrosylation in subsarcolemmal mitochondria","volume":"106","author":"Sun","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib648","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/MCB.00224-07","article-title":"Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II","volume":"28","author":"Sun","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1124\/pharmrev.121.000348_bib649","doi-asserted-by":"crossref","first-page":"55187","DOI":"10.18632\/oncotarget.19232","article-title":"Acute atorvastatin treatment restores the cardioprotective effects of ischemic postconditioning in hyperlipidemic rats","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1124\/pharmrev.121.000348_bib650","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.3390\/ijms21113744","article-title":"Hypercholesterolemia Interferes with Induction of miR-125b-1-3p in Preconditioned Hearts","volume":"21","author":"Szab\u00f3","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.121.000348_bib651","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1111\/jcmm.13697","article-title":"Cardioprotection of ischaemic preconditioning is associated with inhibition of translocation of MLKL within the plasma membrane","volume":"22","author":"Szobi","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1124\/pharmrev.121.000348_bib652","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12967-017-1189-5","article-title":"Analysis of necroptotic proteins in failing human hearts","volume":"15","author":"Szobi","year":"2017","journal-title":"J Transl Med"},{"key":"10.1124\/pharmrev.121.000348_bib653","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.RES.86.3.270","article-title":"Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff mouse heart","volume":"86","author":"Tada","year":"2000","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib654","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvab010","article-title":"NLRP3 inflammasome as a key driver of vascular disease","volume":"118","author":"Takahashi","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib655","doi-asserted-by":"crossref","first-page":"H437","DOI":"10.1152\/ajpheart.00384.2010","article-title":"eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex","volume":"299","author":"Talukder","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib656","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/JOE-17-0457","article-title":"Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury","volume":"236","author":"Tanajak","year":"2018","journal-title":"J Endocrinol"},{"key":"10.1124\/pharmrev.121.000348_bib657","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcard.2012.03.136","article-title":"Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial","volume":"162","author":"Tarantini","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib658","doi-asserted-by":"crossref","first-page":"F579","DOI":"10.1152\/ajprenal.00442.2014","article-title":"Mitochondrial dysfunction in uremic cardiomyopathy","volume":"308","author":"Taylor","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib659","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCRESAHA.118.313341","article-title":"Effect of Intracoronary Metformin on Myocardial Infarct Size in Swine","volume":"123","author":"Techiryan","year":"2018","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib660","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/cvr\/cvaa263","article-title":"Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment","volume":"117","author":"Ten Cate","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib661","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/heartjnl-2018-313705","article-title":"Out-of-hospital initiation of hypothermia in ST-segment elevation myocardial infarction: a randomised trial","volume":"105","author":"Testori","year":"2019","journal-title":"Heart"},{"key":"10.1124\/pharmrev.121.000348_bib662","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.107.729780","article-title":"Long-term benefit of postconditioning","volume":"117","author":"Thibault","year":"2008","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib663","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(13)61450-6","article-title":"Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial","volume":"382","author":"Thielmann","year":"2013","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.121.000348_bib664","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.jacc.2012.03.026","article-title":"Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction","volume":"59","author":"Thuny","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib665","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib666","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacc.2008.10.033","article-title":"Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury","volume":"53","author":"Timmers","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib667","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European Society of Cardiology: cardiovascular disease statistics 2021","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib668","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/01.CIR.76.3.667","article-title":"The efficacy of intermittent coronary sinus occlusion in the absence of coronary artery collaterals","volume":"76","author":"Toggart","year":"1987","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib669","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijcard.2016.02.043","article-title":"Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse","volume":"209","author":"Toldo","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib670","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1213\/ANE.0000000000005243","article-title":"Perioperative cardioprotection: general mechanisms and pharmacological approaches","volume":"131","author":"Torregroza","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1124\/pharmrev.121.000348_bib671","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/CIRCRESAHA.118.314060","article-title":"NHLBI-sponsored randomized trial of postconditioning during primary percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"124","author":"Traverse","year":"2019","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib672","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.2337\/diabetes.54.8.2360","article-title":"Preconditioning the diabetic heart: the importance of Akt phosphorylation","volume":"54","author":"Tsang","year":"2005","journal-title":"Diabetes"},{"key":"10.1124\/pharmrev.121.000348_bib673","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/1074248419841632","article-title":"A review of humoral factors in remote preconditioning of the heart","volume":"24","author":"Tsibulnikov","year":"2019","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1124\/pharmrev.121.000348_bib674","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.RES.75.3.576","article-title":"Alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C","volume":"75","author":"Tsuchida","year":"1994","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib675","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00395-006-0585-4","article-title":"Ischemic preconditioning depends on age and gender","volume":"101","author":"Turcato","year":"2006","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib676","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13105-019-00664-w","article-title":"Diabetes abolish cardioprotective effects of remote ischemic conditioning: evidences and possible mechanisms","volume":"75","author":"Tyagi","year":"2019","journal-title":"J Physiol Biochem"},{"key":"10.1124\/pharmrev.121.000348_bib677","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/cvr\/cvz004","article-title":"Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts","volume":"115","author":"Uthman","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib678","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/01.RES.79.3.407","article-title":"No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine","volume":"79","author":"Vahlhaus","year":"1996","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib679","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib680","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/cvr\/cvv279","article-title":"Succinate dehydrogenase inhibition with malonate during reperfusion reduces infarct size by preventing mitochondrial permeability transition","volume":"109","author":"Valls-Lacalle","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib681","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/s41598-018-20866-4","article-title":"Selective inhibition of succinate dehydrogenase in reperfused myocardium with intracoronary malonate reduces infarct size","volume":"8","author":"Valls-Lacalle","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000348_bib682","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchf.2019.08.014","article-title":"Left ventricular post-infarct remodeling: implications for systolic function improvement and outcomes in the modern era","volume":"8","author":"van der Bijl","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1124\/pharmrev.121.000348_bib683","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2261-10-45","article-title":"Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model","volume":"10","author":"van der Pals","year":"2010","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1124\/pharmrev.121.000348_bib684","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/jth.15289","article-title":"Off-target effects of oral anticoagulants\u2014vascular effects of vitamin K antagonist and non-vitamin K antagonist oral anticoagulant dabigatran etexilate","volume":"19","author":"van Gorp","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pharmrev.121.000348_bib685","first-page":"828","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"van Hout","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib686","first-page":"100816","article-title":"Right atrial blood supply and complexity of induced atrial fibrillation: what\u2019s left?","volume":"34","author":"Van Wagoner","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1124\/pharmrev.121.000348_bib687","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/heartjnl-2018-313091","article-title":"Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial","volume":"104","author":"Vanezis","year":"2018","journal-title":"Heart"},{"key":"10.1124\/pharmrev.121.000348_bib688","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2017.12.010","article-title":"miR-125b is a protectomiR: a rising star for acute cardioprotection","volume":"115","author":"Varga","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib689","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2174\/1389450116666150427154203","article-title":"Functional genomics of cardioprotection by ischemic conditioning and the influence of comorbid conditions: implications in target identification","volume":"16","author":"Varga","year":"2015","journal-title":"Curr Drug Targets"},{"key":"10.1124\/pharmrev.121.000348_bib690","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yjmcc.2013.05.009","article-title":"MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative\/nitrative stress and subsequent dysfunction in the heart","volume":"62","author":"Varga","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib691","doi-asserted-by":"crossref","first-page":"H216","DOI":"10.1152\/ajpheart.00812.2013","article-title":"MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre- and postconditioning: protectomiRs","volume":"307","author":"Varga","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib692","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40256-018-0266-3","article-title":"Cardioprotection by metformin: beneficial effects beyond glucose reduction","volume":"18","author":"Varjabedian","year":"2018","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1124\/pharmrev.121.000348_bib693","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1161\/CIRCULATIONAHA.115.016595","article-title":"Does myocardial infarction beget atrial fibrillation and atrial fibrillation beget myocardial infarction?","volume":"131","author":"Vermond","year":"2015","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib694","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ahj.2016.08.004","article-title":"Effect of remote ischemic conditioning on infarct size in patients with anterior ST-elevation myocardial infarction","volume":"181","author":"Verouhis","year":"2016","journal-title":"Am Heart J"},{"key":"10.1124\/pharmrev.121.000348_bib695","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jacc.2015.02.026","article-title":"Plasma exosomes protect the myocardium from ischemia-reperfusion injury","volume":"65","author":"Vicencio","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib696","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fphys.2014.00496","article-title":"Ischemia\/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor","volume":"5","author":"Vilahur","year":"2014","journal-title":"Front Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib697","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCULATIONAHA.113.008157","article-title":"Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia\/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging","volume":"130","author":"von Elverfeldt","year":"2014","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib698","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/FJC.0b013e3182760c4d","article-title":"Cardioprotection by ischemic postconditioning is abrogated in hypertrophied myocardium of spontaneously hypertensive rats","volume":"61","author":"Wagner","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib699","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1006\/jmcc.1996.0169","article-title":"No attenuation of ischaemic preconditioning by the calcium antagonist nisoldipine","volume":"28","author":"Wallbridge","year":"1996","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib700","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ejcts.2008.07.062","article-title":"Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials","volume":"34","author":"Walsh","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1124\/pharmrev.121.000348_bib701","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1213\/01.ANE.0000230389.76351.0C","article-title":"Gender-specificity of delayed preconditioning by isoflurane in rabbits: potential role of endothelial nitric oxide synthase","volume":"103","author":"Wang","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1124\/pharmrev.121.000348_bib702","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4196\/kjpp.2021.25.3.239","article-title":"Hydrogen sulfide restores cardioprotective effects of remote ischemic preconditioning in aged rats via HIF-1\u03b1\/Nrf2 signaling pathway","volume":"25","author":"Wang","year":"2021","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib703","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/jth.12243","article-title":"Antithrombin is protective against myocardial ischemia and reperfusion injury","volume":"11","author":"Wang","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"14, Suppl","key":"10.1124\/pharmrev.121.000348_bib704","first-page":"S38","article-title":"Mechanisms of sex differences in TNFR2-mediated cardioprotection","volume":"118","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib705","doi-asserted-by":"crossref","first-page":"E872","DOI":"10.1152\/ajpendo.00251.2007","article-title":"Sex differences in endothelial STAT3 mediate sex differences in myocardial inflammation","volume":"293","author":"Wang","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/pharmrev.121.000348_bib706","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/BF00788727","article-title":"Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts","volume":"91","author":"Wang","year":"1996","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib707","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00424-021-02515-4","article-title":"The crosstalk between cardiomyocyte calcium and inflammasome signaling pathways in atrial fibrillation","volume":"473","author":"Wang","year":"2021","journal-title":"Pflugers Arch"},{"key":"10.1124\/pharmrev.121.000348_bib708","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvu044","article-title":"MicroRNA-125b protects against myocardial ischaemia\/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6","volume":"102","author":"Wang","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib709","article-title":"Thrombin aggravates hypoxia\/reoxygenation injury of cardiomyocytes by activating an autophagy pathway-mediated by SIRT1","volume":"27","author":"Wang","year":"2021","journal-title":"Med Sci Monit"},{"key":"10.1124\/pharmrev.121.000348_bib710","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12899-017-0030-y","article-title":"Myocardial susceptibility to ischaemia\/reperfusion in obesity: a re-evaluation of the effects of age","volume":"17","author":"Webster","year":"2017","journal-title":"BMC Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib711","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/CIRCRESAHA.110.236190","article-title":"Repeated remote ischemic postconditioning protects against adverse left ventricular remodeling and improves survival in a rat model of myocardial infarction","volume":"108","author":"Wei","year":"2011","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib712","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cardiores.2005.10.016","article-title":"Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction","volume":"69","author":"Weil","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib713","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib714","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1093\/eurheartj\/ehz299","article-title":"Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial","volume":"40","author":"White","year":"2019","journal-title":"Eur Heart J"},{"issue":"1 Pt B","key":"10.1124\/pharmrev.121.000348_bib715","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jcin.2014.05.015","article-title":"Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction","volume":"8","author":"White","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1124\/pharmrev.121.000348_bib716","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib717","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/cvr\/cvt140","article-title":"Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling","volume":"99","author":"Whittington","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib718","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00395-018-0674-1","article-title":"Remote ischemic preconditioning fails to reduce infarct size in the Zucker fatty rat model of type-2 diabetes: role of defective humoral communication","volume":"113","author":"Wider","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib719","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/cells9051159","article-title":"Cell-free circulating mitochondrial DNA: a potential blood-based marker for atrial fibrillation","volume":"9","author":"Wiersma","year":"2020","journal-title":"Cells"},{"key":"10.1124\/pharmrev.121.000348_bib720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101446","article-title":"Effects of exogenous recombinant APC in mouse models of ischemia reperfusion injury and of atherosclerosis","volume":"9","author":"Wildhagen","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib721","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.atherosclerosis.2013.11.082","article-title":"Atherosclerosis and atrial fibrillation\u2014two closely intertwined diseases","volume":"233","author":"Willeit","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1124\/pharmrev.121.000348_bib722","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00395-020-0799-x","article-title":"Anaemia is associated with severe RBC dysfunction and a reduced circulating NO pool: vascular and cardiac eNOS are crucial for the adaptation to anaemia","volume":"115","author":"Wischmann","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib723","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamacardio.2020.0764","article-title":"Effect of evolocumab on type and size of subsequent myocardial infarction: a prespecified analysis of the FOURIER randomized clinical trial","volume":"5","author":"Wiviott","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib724","article-title":"Beta-blockers for hypertension","volume":"1","author":"Wiysonge","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pharmrev.121.000348_bib725","article-title":"Non-ischemic heart preconditioning","volume":"69","author":"Wojcik","year":"2018","journal-title":"J Physiol Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib726","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00395-020-00824-w","article-title":"Autocrine effects of PCSK9 on cardiomyocytes","volume":"115","author":"Wolf","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib727","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0008-6363(02)00408-X","article-title":"Remote preconditioning protects the heart by activating myocardial PKCepsilon-isoform","volume":"55","author":"Wolfrum","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib728","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1161\/ATVBAHA.113.301586","article-title":"Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study","volume":"33","author":"Woo","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pharmrev.121.000348_bib729","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12013-013-9778-2","article-title":"Hypercholesterolemia abrogates the cardioprotection of ischemic postconditioning in isolated rat heart: roles of glycogen synthase kinase-3\u03b2 and the mitochondrial permeability transition pore","volume":"69","author":"Wu","year":"2014","journal-title":"Cell Biochem Biophys"},{"key":"10.1124\/pharmrev.121.000348_bib730","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.3892\/mmr.2017.7051","article-title":"lncRNA expression character associated with ischemic reperfusion injury","volume":"16","author":"Wu","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1124\/pharmrev.121.000348_bib731","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/01.fjc.0000188365.07635.57","article-title":"Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42\/44MAPK","volume":"46","author":"Wynne","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pharmrev.121.000348_bib732","doi-asserted-by":"crossref","first-page":"712478","DOI":"10.3389\/fcvm.2021.712478","article-title":"Cardioprotecive properties of known agents in rat ischemia-reperfusion model under clinically relevant conditions: only the NAD precursor nicotinamide riboside reduces infarct size in presence of fentanyl, midazolam and cangrelor, but not propofol","volume":"8","author":"Xiao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1124\/pharmrev.121.000348_bib733","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41598-019-56897-8","article-title":"Sevoflurane pre-conditioning ameliorates diabetic myocardial ischemia\/reperfusion injury via differential regulation of p38 and ERK","volume":"10","author":"Xie","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000348_bib734","doi-asserted-by":"crossref","first-page":"104313","DOI":"10.1016\/j.mvr.2022.104313","article-title":"Remote cyclic compression ameliorates myocardial infarction injury in rats via AMPK-dependent pathway","volume":"141","author":"Xu","year":"2022","journal-title":"Microvasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib735","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2014.10.144","article-title":"Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction","volume":"178","author":"Yamaguchi","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib736","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098972","article-title":"Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion","volume":"9","author":"Yamamoto","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.121.000348_bib737","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1399-6576.2007.01487.x","article-title":"Lidocaine abolishes the myocardial protective effect of sevoflurane post-conditioning","volume":"52","author":"Yan","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1124\/pharmrev.121.000348_bib738","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-013-6474-9","article-title":"Triple therapy greatly increases myocardial salvage during ischemia\/reperfusion in the in situ rat heart","volume":"27","author":"Yang","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/pharmrev.121.000348_bib739","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1074248412467692","article-title":"Platelet P2Y12 blockers confer direct postconditioning-like protection in reperfused rabbit hearts","volume":"18","author":"Yang","year":"2013","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1124\/pharmrev.121.000348_bib740","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10557-012-6436-7","article-title":"Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts","volume":"27","author":"Yang","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/pharmrev.121.000348_bib741","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/HYPERTENSIONAHA.110.158469","article-title":"Hypertensive hypertrophied myocardium is vulnerable to infarction and refractory to erythropoietin-induced protection","volume":"57","author":"Yano","year":"2011","journal-title":"Hypertension"},{"key":"10.1124\/pharmrev.121.000348_bib742","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib743","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.CIR.81.1.156","article-title":"The complement system in ischemic heart disease","volume":"81","author":"Yasuda","year":"1990","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib744","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10557-017-6725-2","article-title":"SGLT-2 inhibition with dapagliflozin reduces the activation of the Nlrp3\/ASC inflammasome and attenuates the development of diabetic cardiomyopathy in mice with type 2 diabetes. Further augmentation of the effects with saxagliptin, a DPP4 inhibitor","volume":"31","author":"Ye","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/pharmrev.121.000348_bib745","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00395-011-0216-6","article-title":"The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury","volume":"106","author":"Ye","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib746","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCRESAHA.113.300636","article-title":"Exosomes: nanoparticles involved in cardioprotection?","volume":"114","author":"Yellon","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/pharmrev.121.000348_bib747","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00395-018-0681-2","article-title":"The GTN patch: a simple and effective new approach to cardioprotection?","volume":"113","author":"Yellon","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib748","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41467-021-20942-w","article-title":"Structural basis for a complex I mutation that blocks pathological ROS production","volume":"12","author":"Yin","year":"2021","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.121.000348_bib749","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1916841","article-title":"H2O2 signaling-triggered PI3K mediates mitochondrial protection to participate in early cardioprotection by exercise preconditioning","volume":"2018","author":"Yuan","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1124\/pharmrev.121.000348_bib750","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ejhf.1473","article-title":"Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction","volume":"21","author":"Yurista","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1124\/pharmrev.121.000348_bib751","first-page":"I32","article-title":"Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction","volume":"67","author":"Yusuf","year":"1983","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.121.000348_bib752","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00395-015-0475-8","article-title":"Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion","volume":"110","author":"Zalewski","year":"2015","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/pharmrev.121.000348_bib753","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.avsg.2020.02.005","article-title":"Factor Xa Inhibition by rivaroxaban modified mitochondrial-associated proteins in human abdominal aortic aneurysms","volume":"67","author":"Zamorano-Leon","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1124\/pharmrev.121.000348_bib754","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease","volume":"379","author":"Zannad","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib755","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1056\/NEJMe1510338","article-title":"Remote ischemic preconditioning in cardiac surgery\u2014ineffective and risky?","volume":"373","author":"Zaugg","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000348_bib756","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.2174\/1381612820666140204120829","article-title":"Anesthetic cardioprotection in clinical practice from proof-of-concept to clinical applications","volume":"20","author":"Zaugg","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pharmrev.121.000348_bib757","doi-asserted-by":"crossref","first-page":"24270","DOI":"10.18632\/aging.202143","article-title":"Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK\/NLRP3 inflammasome pathway","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1124\/pharmrev.121.000348_bib758","first-page":"666","article-title":"Different postconditioning cycles affect prognosis of aged patients undergoing primary percutaneous coronary intervention","volume":"25","author":"Zhang","year":"2018","journal-title":"Cardiol J"},{"key":"10.1124\/pharmrev.121.000348_bib759","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.4017","article-title":"CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis","volume":"22","author":"Zhang","year":"2016","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.121.000348_bib760","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0267659108094628","article-title":"Carvedilol reduces myocardial no-reflow by decreasing endothelin-1 via activation of the ATP-sensitive K+ channel","volume":"23","author":"Zhao","year":"2008","journal-title":"Perfusion"},{"key":"10.1124\/pharmrev.121.000348_bib761","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.mvr.2006.09.002","article-title":"Different effects of postconditioning on myocardial no-reflow in the normal and hypercholesterolemic mini-swines","volume":"73","author":"Zhao","year":"2007","journal-title":"Microvasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib762","doi-asserted-by":"crossref","first-page":"H579","DOI":"10.1152\/ajpheart.01064.2002","article-title":"Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning","volume":"285","author":"Zhao","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pharmrev.121.000348_bib763","first-page":"126","article-title":"Common differentially expressed genes and pathways correlating both coronary artery disease and atrial fibrillation","volume":"20","author":"Zheng","year":"2021","journal-title":"EXCLI J"},{"key":"10.1124\/pharmrev.121.000348_bib764","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasome activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"key":"10.1124\/pharmrev.121.000348_bib765","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005328","article-title":"Mff-dependent mitochondrial fission contributes to the pathogenesis of cardiac microvasculature ischemia\/reperfusion injury via induction of mROS-mediated cardiolipin oxidation and HK2\/VDAC1 disassociation-involved mPTP opening","volume":"6","author":"Zhou","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pharmrev.121.000348_bib766","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1124\/pharmrev.121.000348_bib767","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1038\/s41467-021-24804-3","article-title":"Nitrate-functionalized patch confers cardioprotection and improves heart repair after myocardial infarction via local nitric oxide delivery","volume":"12","author":"Zhu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.121.000348_bib768","doi-asserted-by":"crossref","first-page":"38161","DOI":"10.1038\/srep38161","article-title":"Highly Sensitive detection of minimal cardiac ischemia using positron emission tomography imaging of activated platelets","volume":"6","author":"Ziegler","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000348_bib769","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/cvr\/cvz070","article-title":"Platelets in cardiac ischaemia\/reperfusion injury: a promising therapeutic target","volume":"115","author":"Ziegler","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pharmrev.121.000348_bib770","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2147\/JIR.S284471","article-title":"Repurposing FDA approved drugs as JNK3 inhibitor for prevention of neuroinflammation induced by MCAO in rats","volume":"13","author":"Zulfiqar","year":"2020","journal-title":"J Inflamm Res"},{"key":"10.1124\/pharmrev.121.000348_bib771","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1111\/jcmm.15180","article-title":"Cardiac metabolism as a driver and therapeutic target of myocardial infarction","volume":"24","author":"Zuurbier","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1124\/pharmrev.121.000348_bib772","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12967-014-0325-8","article-title":"Cardioprotective efficacy depends critically on pharmacological dose, duration of ischaemia, health status of animals and choice of anaesthetic regimen: a case study with folic acid","volume":"12","author":"Zuurbier","year":"2014","journal-title":"J Transl Med"},{"key":"10.1124\/pharmrev.121.000348_bib773","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00424-001-0744-2","article-title":"Post-ischaemic changes in the response time of oxygen consumption to demand in the isolated rat heart are mediated partly by calcium and glycolysis","volume":"443","author":"Zuurbier","year":"2002","journal-title":"Pflugers Arch"},{"key":"10.1124\/pharmrev.121.000348_bib774","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040643","article-title":"Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6\/STAT3 signaling","volume":"7","author":"Zuurbier","year":"2012","journal-title":"PLoS One"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724007506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724007506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pharmrev.121.000348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:44:43Z","timestamp":1740746683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724007506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":781,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0031699724007506"],"URL":"https:\/\/doi.org\/10.1124\/pharmrev.121.000348","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia\/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pharmrev.121.000348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The Author(s)","name":"copyright","label":"Copyright"}]}}